<div class="chapter"><div class="chapter"><h2 class="title">CHAPTER 28. <a name="page560"></a><span class="pageBreak"></span><span class="pageNumbers"><span class="bottomPage">560</span></span>Miscellaneous</h2><div class="section" id="ch28lev1sec1"><h1 class="title">LASER IN OPHTHALMOLOGY</h1>
<p class="noindent">Laser is the acronym of <bold>light amplification by stimulated emission of radiation.</bold></p>
<div class="section" id="ch28lev2sec1"><h2 class="title">Physics</h2>
<p class="noindent">Certain substances have the property to “lase”, to absorb energy in one form, and to emit a new form of light. On pumping, these “lasing” substances are able to transfer electrons from a lower orbit to the higher metastable orbit <span class="italic">(Bohr's theory)</span>. The excited atoms in turn decay back to their original orbit to lower energy, thus emitting a new form of photons. This decaying can be spontaneous or induced <span class="italic">(stimulate demission)</span>. These photons are then passed through a close system of mirrors, which leads to <span class="italic">light amplification</span>, and delivered as <span class="italic">laser</span>.</p>
</div>
<div class="section" id="ch28lev2sec2"><h2 class="title">Common Types of Laser</h2>
<p class="noindent">Common types of laser used in ophthalmology have been described in <bold><a href="#ch28tbl1" class="ulink-inter">Table 28.1</a></bold>.</p>
</div>
<div class="section" id="ch28lev2sec3"><h2 class="title">Properties of Laser</h2>
<ul style="list-style-type: bullet">
<li><p class="">It is always <span class="italic">monochromatic</span> (has got one wavelength of light).</p></li>
<li><p class="">It is <span class="italic">collimated</span> (all photons run parallel).</p></li>
<li><p class="">It is <span class="italic">coherent</span> (always in the same phase).</p></li>
<li><p class="">It is <span class="italic">polarized</span> at high energy level.</p></li>
</ul>
<div class="section" id="ch28lev3sec1"><h3 class="title">Laser Effects on Ocular Tissues</h3>
<ul style="list-style-type: bullet">
<li><p class=""><span class="italic">Photocoagulation (controlled burn):</span> Argon laser, diode laser, krypton laser.</p></li>
<li><p class=""><span class="italic">Photovaporization:</span> Argon laser, diode laser.</p></li>
<li><p class=""><span class="italic">Photodisruption (optical breakdown to disrupt tissues by the formation of plasma):</span> Nd:YAG laser, femtosecond laser.</p></li>
<li><p class=""><span class="italic">Photoablation (ablation of corneal tissue without thermal damage):</span> Excimer laser.</p></li>
</ul>
<div class="table" id="ch28tbl1"><div class="title"><span class="item-label">TABLE 28.1</span> Common types of laser.</div><div class="table-scroll"><table data-label="TABLE 28.1" class="download">


<thead>
<tr>
<th class="left"><p class=""><span class="italic">Types of laser</span></p></th>
<th class="left"><p class=""><span class="italic">Wavelengths</span></p></th>
</tr>
</thead>
<tbody>
<tr>
<td class="left"><p class=""><span class="italic">Ruby laser</span> (first laser)</p></td>
<td class="left"><p class="">550 nm</p></td>
</tr>
<tr>
<td class="left"><p class=""><span class="italic">Argon laser</span></p>
<p class=""><ul style="list-style-type: bullet">
<li><p class="">Blue-green</p></li>
<li><p class="">Pure-green</p></li>
</ul></p></td>
<td class="left"><p class="">488 nm</p>
<p class="">518 nm</p></td>
</tr>
<tr>
<td class="left"><p class=""><span class="italic">Krypton laser</span></p></td>
<td class="left"><p class="">647 nm</p></td>
</tr>
<tr>
<td class="left"><p class=""><span class="italic">Nd-YAG laser</span> (Neodymium: Yttrium-Aluminum Garnet)</p>
<p class=""><ul style="list-style-type: bullet">
<li><p class="">Single frequency</p></li>
<li><p class="">Double frequency (pulsed)</p></li>
</ul></p></td>
<td class="left"><p class="">1064 nm</p>
<p class="">532 nm</p></td>
</tr>
<tr>
<td class="left"><p class=""><span class="italic">Diode laser</span></p>
<p class=""><ul style="list-style-type: bullet">
<li><p class="">Produced from semiconductor crystals</p></li>
<li><p class="">Lasing substance: Gallium-aluminum-arsenate</p></li>
</ul></p></td>
<td class="left"><p class="">810 nm</p></td>
</tr>
<tr>
<td class="left"><p class=""><span class="italic">Excimer (excited dimer) laser</span></p>
<p class="">Lasing substance: Argon fluoride</p></td>
<td class="left"><p class="">193 nm</p></td>
</tr>
<tr>
<td class="left"><p class=""><span class="italic">Femtosecond laser</span></p>
<p class="">Nd: Glass</p></td>
<td class="left"><p class="">1053 nm</p></td>
</tr>
</tbody>
</table></div><div class="additional-markup"></div></div>
</div>
</div>
<div class="section" id="ch28lev2sec4"><h2 class="title">Indications of Laser (in General)</h2>
<div class="section" id="ch28lev3sec2"><h3 class="title">Common Indications</h3>
<ul style="list-style-type: bullet">
<li><p class="">Iridotomy for angle-closure glaucoma</p></li>
<li><p class="">Pupilloplasty<a name="page561"></a><span class="pageBreak"></span><span class="pageNumbers"><span class="bottomPage">561</span></span></p></li>
<li><p class="">Argon laser trabeculoplasty (ALT) in primary open-angle glaucoma</p></li>
<li><p class="">Nd:YAG laser capsulotomy for posterior capsular opacification following extracapsular cataract extraction (ECCE)</p></li>
<li><p class="">To create chorioretinal adhesions around the retinal breaks</p></li>
<li><p class="">Panretinal photocoagulation (PRP) for proliferative retinal diseases and rubeosis iridis, e.g., diabetes, central retinal vein occlusion (CRVO)</p></li>
<li><p class="">Central serous retinopathy (CSR)</p></li>
<li><p class="">Direct photocoagulation to treat the vascular abnormalities</p></li>
<li><p class="">“Macular-grid” photocoagulation to treat macular lesions</p></li>
<li><p class="">Intraocular tumors and malignancy</p></li>
<li><p class="">Photorefractive keratoplasty (PRK) in refractive errors by excimer laser</p></li>
<li><p class="">Laser assisted in situ keratomileusis or LASIK for the treatment of refractive errors (mainly myopia)</p></li>
<li><p class="">Phototherapeutic keratoplasty (PTK) with excimer laser for superficial corneal scars</p></li>
<li><p class="">Creation of LASIK flaps and trephination of donor and recipient button in penetrating and lamellar keratoplasty</p></li>
<li><p class="">Femtosecond laser cataract surgery.</p></li>
</ul>
</div>
<div class="section" id="ch28lev3sec3"><h3 class="title">Miscellaneous</h3>
<ul style="list-style-type: bullet">
<li><p class="">Trichiasis (laser cilia-ablation)</p></li>
<li><p class="">Suture removal (laser suturolysis)</p></li>
<li><p class="">Pterygium (to treat the bare area)</p></li>
<li><p class="">Cyclophotocoagulation in glaucoma.</p></li>
<li><p class=""><span class="italic">Diagnostic:</span> Laser-interferometry with helium-neon (He-Ne) laser to test the potential visual acuity in presence of opacity in the media.</p></li>
<li><p class="">Optical coherence tomography (OCT)</p></li>
<li><p class="">Confocal scanning laser ophthalmoscope (cSLO)</p></li>
</ul>
</div>
</div>
<div class="section" id="ch28lev2sec5"><h2 class="title">Femtosecond Laser in Ophthalmology</h2>
<p class="noindent">Femtosecond laser (FS) is an infrared laser (wavelength = 1,053 nm) with ultrashort pulse duration (10–15 seconds). This laser has the ability to deliver laser energy with minimal collateral damage to the adjacent tissue. Thermal damage to neighboring tissue in the cornea has been measured to be around 1 μm.</p>
<ul style="list-style-type: bullet">
<li><p class="">Femtosecond laser works by photodisruption like Nd:YAG laser, a process in which small volumes of tissue are vaporized resulting in the formation of cavitation gas (CO<sub>2</sub> and water) bubbles.</p></li>
<li><p class="">Furthermore, the unique Femto laser can be focused anywhere within or behind the cornea and is capable of passing through optically hazy media, such as an edematous cornea or cataractous lens. It may be applied in multiple geometric patterns including vertical, horizontal, spiral or zigzag cuts.</p></li>
<li><p class="">There are multiple commercially available femtosecond laser models in the market.</p></li>
</ul>
<div class="section" id="ch28lev3sec4"><h3 class="title">Femtosecond Laser in Refractive Surgery</h3>
<ul style="list-style-type: bullet">
<li><p class=""><span class="italic">Flap creation in LASIK:</span> Corneal flap creation in LASIK is the most common use of Femto laser. It has many advantages over mechanical microkeratome flap, like—fewer flap related complications, thinner flap, improved thickness predictability and less induced higher order aberrations.</p></li>
<li><p class=""><span class="italic">Femtosecond lenticule extraction (FLEx):</span> It is a new procedure to correct myopia and myopic astigmatism. This procedure involves making two cuts (anterior and posterior) that intersect in the periphery, creating a lenticule which is ultimately removed.</p></li>
<li><p class=""><span class="italic">Small incision lenticule extraction (SMILE):</span> A procedure in which the corneal flap is eliminated and instead a small incision is created in the mid-periphery of the cornea and the lenticule is removed through this self-sealing incision. SMILE has less tendency to induce post-refractive surgery dry eye, ectasia, and least flap complications.</p></li>
</ul>
</div>
<div class="section" id="ch28lev3sec5"><h3 class="title">Intracorneal Ring Segments</h3>
<ul style="list-style-type: bullet">
<li><p class="">Intracorneal ring segments (INTACS) are arcuate, polymethyl methacrylate (PMMA) <a name="page562"></a><span class="pageBreak"></span><span class="pageNumbers"><span class="bottomPage">562</span></span>implants for intrastromal insertion in midperipheral cornea for correction of milder cases of keratoconus with up to −3.50D of myopia and without central scarring.</p></li>
<li><p class="">Femtosecond laser creates arcuate tunnels at 70% corneal depth. This method is easier and safer than manual dissection.</p></li>
</ul>
</div>
<div class="section" id="ch28lev3sec6"><h3 class="title">Femtosecond Laser for Presbyopia Correction</h3>
<p class="noindent">Femtosecond laser can be used to create intrastromal pockets for the implantation of IntraCor or the Kamra small aperture corneal inlay which help to correct presbyopia.</p>
</div>
<div class="section" id="ch28lev3sec7"><h3 class="title">Femtosecond Laser in Corneal Transplantation</h3>
<ul style="list-style-type: bullet">
<li><p class=""><span class="italic">Penetrating keratoplasty (PK):</span> Femtosecond laser creates complex pattern trephination cuts for enhanced wound integrity of the graft-host junction. Theoretically it may decrease suture-induced astigmatism and allow for faster visual recovery. The cuts include top hat (larger diameter cut posteriorly), mushroom (larger diameter anteriorly), zigzag and Christmas tree pattern. Mushroom cut may be advantageous in keratoconus by providing a larger anterior refractive surface while the top hat may be useful in endothelial disorders by replacing more endothelial cells.</p></li>
<li><p class=""><span class="italic">Anterior lamellar keratoplasty (ALK):</span> Femtosecond-assisted sutureless anterior lamellar keratoplasty can be used to treat anterior corneal pathologies with less irregular astigmatism and faster visual rehabilitation. Femtosecond-assisted DALK (deep anterior lamellar keratoplasty) is also a promising development.</p></li>
<li><p class=""><span class="italic">Descemet's stripping automated endothelial keratoplasty) (DSAEK):</span> Femtosecond laser can be used to create the lenticule for insertion in DSAEK procedure. The results are equal to or better than microkeratome assisted DSAEK.</p></li>
</ul>
</div>
<div class="section" id="ch28lev3sec8"><h3 class="title">Femtosecond Laser and Astigmatic Keratotomy and Arcuate Wedge Resection</h3>
<p class="noindent">Femtosecond laser may be used in astigmatic keratotomy (AK) and/or arcuate wedge resection for the correction of high astigmatism following penetrating keratoplasty (PK) or cataract surgery. This laser procedure is easier, more precise and carries less risk of perforation than diamond blade method.</p>
</div>
<div class="section" id="ch28lev3sec9"><h3 class="title">Femtosecond Laser-assisted Cataract Surgery (FLACS)</h3>
<ul style="list-style-type: bullet">
<li><p class="">Femtosecond laser are now used routinely in cataract surgery to create capsulotomy, clear corneal incision, limbal relaxing incisions, and lens fragmentation.</p></li>
<li><p class="">Incisions (main incision and paracentesis) created by the laser are more precise, stable and with faster wound healing.</p></li>
<li><p class="">The capsulorhexis created by the laser is more precisely centered and measured leading to better outcomes in premium intraocular lenses (IOLs) like multifocal and toric IOLs.</p></li>
<li><p class="">Lens fragmentation with the laser leads to lesser phaco energy being used and thus lesser endothelial damage.</p></li>
<li><p class="">Visual recovery is also faster.</p></li>
<li><p class="">Cystoid macular edema may be less in Femto laser as compared to conventional phacoemulsification.</p></li>
</ul>
</div>
</div>
</div><div class="section" id="ch28lev1sec2"><h1 class="title">CRYOTHERAPY IN OPHTHALMOLOGY</h1>
<p class="noindent">Cryotherapy is a technique to injure, or to adhere tissues by the application of intense cold.</p>
<ul style="list-style-type: bullet">
<li><p class="">This is achieved by a <span class="italic">cryoprobe,</span> a pencillike instrument held by the surgeon, and it is cooled at a temperature of −40°C to −100°C by a freezer gas under pressure. The gas flow to the cryoprobe is controlled by a foot-switch.</p></li>
<li><p class="">The <span class="italic">gases used</span> are nitrous oxide (liquid nitrogen), freon or solid carbon dioxide.<a name="page563"></a><span class="pageBreak"></span><span class="pageNumbers"><span class="bottomPage">563</span></span></p></li>
</ul>
<div class="section" id="ch28lev2sec6"><h2 class="title">Principle</h2>
<p class="noindent"><span class="italic">Joule-Thomson effect</span><bold>—</bold>when a gas (cryogen) is released under high pressure through a micro-orifice, the gas expands to reach at its boiling point to reduce the temperature (e.g., liquid nitrogen boils at −195.6°C, and is an excellent cryogen).</p>
</div>
<div class="section" id="ch28lev2sec7"><h2 class="title">Mechanism</h2>
<p class="noindent">When the freezing source is applied to a tissue, there is formation of hemispherical ice ball which has different temperature zones.</p>
<ul style="list-style-type: bullet">
<li><p class="">The temperature at any point within the ice ball depends upon:
<ul style="list-style-type: square">
<li><p class="">The distance from the cryogen.</p></li>
<li><p class="">The rate and duration of freezing.</p></li>
</ul></p></li>
<li><p class=""><span class="italic">Two basic mechanisms</span> involved in cryotherapy are:
<ol style="list-style-type: lower-roman">
<li><p class=""><span class="italic">Cryoadhesion</span> (as in ICCE or retinal breaks).</p></li>
<li><p class=""><span class="italic">Cryoinjury</span> (in vivo cell death), which has two phases:</p>
<ol style="list-style-type: lower-alpha">
<li><p class=""><span class="italic">Initial phase:</span> (i) Extracellular ice crystal formation → dehydration → cell death. (ii) Intracellular ice crystal formation cell death.</p></li>
<li><p class=""><span class="italic">Late phase:</span> Damage to the microcirculation of the cells → ischemic necrosis.</p></li>
</ol></li>
</ol></p></li>
</ul>
<p class="noindent"><span class="italic">Maximum cell death is best achieved with a “rapid freeze” and a “slow thaw”.</span></p>
<p class="noindent"><span class="italic">The three different probes are:</span></p>
<ol style="list-style-type: decimal">
<li><p class=""><span class="italic">Cataract probe:</span> −40°C to −50°C</p></li>
<li><p class=""><span class="italic">Retinal probe:</span> −50°C to −70°C</p></li>
<li><p class=""><span class="italic">Glaucoma probe:</span> −60°C to −80°C</p></li>
</ol>
</div>
<div class="section" id="ch28lev2sec8"><h2 class="title">Use of Cryo in Ophthalmology</h2>
<ul style="list-style-type: bullet">
<li><p class=""><span class="italic">Eyelids:</span> Papilloma, molluscum contagiosum, trichiasis, basal cell carcinoma, xanthelasma, etc.</p></li>
<li><p class=""><span class="italic">Conjunctiva:</span> Cystoid cicatrix, giant papillae in vernal conjunctivitis and ocular surface squamous neoplasia (OSSN)</p></li>
<li><p class=""><span class="italic">Cornea:</span> Herpes simplex keratitis (epithelial or stromal), epithelial downgrowth, carcinoma in situ</p></li>
<li><p class=""><span class="italic">Iris and ciliary body:</span> Prolapsed iris, cyclocryopexy for absolute glaucoma.</p></li>
<li><p class=""><span class="italic">Lens:</span> Intracapsular cataract extraction</p></li>
<li><p class=""><span class="italic">Retina:</span>
<ul style="list-style-type: square">
<li><p class="">To seal the peripheral retinal breaks (cryoretinopexy).</p></li>
<li><p class="">To flatten retinoschisis.</p></li>
<li><p class="">To treat retinal neovascularization (when the media is opaque).</p></li>
<li><p class="">To destroy retinal neoplasm, either simple (angioma), or malignant (retinoblastoma).</p></li>
</ul></p></li>
</ul>
</div>
</div><div class="section" id="ch28lev1sec3"><h1 class="title">FLUORESCEIN DYE IN OPHTHALMOLOGY</h1>
<p class="noindent"><span class="italic">Sodium fluorescein</span> is a nontoxic, stable highly fluorescent dye. It does not penetrate the cell membrane but remains on its surface.</p>
<p class="indent">When administered parenterally, the dye binds with albumin in the bloodstream, and circulates into the ocular tissues and intraocular fluids.</p>
<p class="indent">The dye absorbs light in the <span class="italic">blue</span> range of visible spectrum, with an <span class="italic">absorption peak</span> at 465 to 490 nm and after excitation it emits light (fluoresce) in the <span class="italic">green</span> range of visible spectrum, with an <span class="italic">emission peak</span> at 520 to 530 nm. This color change can be detected even at a dilution of 1 in 1,000,000 by using ultraviolet light.</p>
<p class="indent">After intravenous (IV) injection, fluorescein dye is eliminated from the body through the kidneys and liver within 24–36 hours.</p>
<div class="section" id="ch28lev2sec9"><h2 class="title">Dosages</h2>
<ul style="list-style-type: bullet">
<li><p class=""><span class="italic">For topical uses</span>—2% solution—1 drop.</p></li>
<li><p class=""><span class="italic">Fluorescein paper strip</span> (available in sterile pouch) convenient to stain cornea and to assess tear film dysfunction.<a name="page564"></a><span class="pageBreak"></span><span class="pageNumbers"><span class="bottomPage">564</span></span></p></li>
<li><p class=""><span class="italic">For fundus fluorescein angiography:</span> 5 mL of 10% solution (most commonly), 10 mL of 5% solution, or 3 mL of 20% solution—as intravenous (IV) bolus injection.</p></li>
</ul>
</div>
<div class="section" id="ch28lev2sec10"><h2 class="title">Adverse Effects of Intravenous Fluorescein Dye</h2>
<ul style="list-style-type: bullet">
<li><p class="">Nausea and vomiting</p></li>
<li><p class="">Vasovagal (syncopal) attack</p></li>
<li><p class="">Painful local extravasation and phlebitis</p></li>
<li><p class="">Pruritus and urticaria</p></li>
</ul>
<p class="indent">Anaphylaxis and bronchospasm (acute emergency) which may be fatal.</p>
</div>
<div class="section" id="ch28lev2sec11"><h2 class="title">Uses of Fluorescein Dye</h2>
<p class="noindent"><span class="italic">Topical uses:</span></p>
<ul style="list-style-type: bullet">
<li><p class="">Staining corneal abrasions or ulcer</p></li>
<li><p class="">Hard contact lens fitting</p></li>
<li><p class="">Tearfilm breakup time (TBUT)</p></li>
<li><p class="">To detect wound leak (Siedel's test)</p></li>
<li><p class="">Applanation tonometry</p></li>
<li><p class="">Patency of the lacrimal passage:
<ul style="list-style-type: square">
<li><p class="">Dye disappearance test (DDT)</p></li>
<li><p class="">Jones test (I and II).</p></li>
</ul></p></li>
<li><p class="">To mark the radial cuts in radial keratotomy, etc.</p></li>
<li><p class="">To check wound integrity at the end of penetrating keratoplasty and sometimes in cataract surgery.</p></li>
</ul>
<p class="noindent"><span class="italic">Intravenous uses:</span></p>
<ul style="list-style-type: bullet">
<li><p class="">Fundus fluorescein angiography.</p></li>
<li><p class="">Fluorescein fluorophotometry to study aqueous outflow or corneal endothelial cell function.</p></li>
<li><p class="">Fluorescein iridography to study iris vascular pattern (e.g., in rubeosis iridis or angioma).</p></li>
<li><p class="">As an antidote for aniline dye poisoning.</p></li>
</ul>
</div>
<div class="section" id="ch28lev2sec12"><h2 class="title">Fundus Fluorescein Angiography</h2>
<p class="noindent">It is a procedure of recording serial photographs (black and white) of retinal and choroidal circulation, and their integrity, after IV injection of fluorescein dye.</p>
<div class="section" id="ch28lev3sec10"><h3 class="title">Normal Angiogram</h3>
<p class="noindent">The dye first appears at the choroid, then the retina, and finally it is drained via the central retinal vein. Normal <bold>“</bold><span class="italic">arm-to-retina”</span> circulation is about 8–12 seconds <span class="italic">(average—10 seconds)</span>. In the choroid, the dye appears about 1 second before the retina.</p>
<p class="noindent"><span class="italic">Fundus fluorescein angiography can be divided into following phases:</span></p>
<ul style="list-style-type: bullet">
<li><p class=""><span class="italic">Choroidal (pre-arterial) phase:</span> When the dye enters into choroidal circulation, a bright glow is seen, known as <span class="italic">choroidal flush</span>. If a <span class="italic">cilioretinal artery</span> is present, it fills during this phase.</p></li>
<li><p class=""><span class="italic">Arterial phase (<a href="#ch28fig1" class="ulink-inter">Fig. 28.1A</a>):</span> The dye appears in the retina through the central retinal artery. The superior and inferior branches fill quickly, and then the whole retinal arterial tree becomes brightly displayed.</p></li>
<li><p class=""><span class="italic">Arteriovenous (capillary) phase:</span> The dye is seen both in the retinal artery and vein. The visualization of capillaries is at its best, during the venous phase.</p></li>
<li><p class=""><span class="italic">Early venous phase (<a href="#ch28fig1" class="ulink-inter">Fig. 28.1B</a>):</span> This phase is marked by <span class="italic">laminar flow</span> which is due to presence of dye on the lateral wall of vein.</p></li>
<li><p class=""><span class="italic">Late venous phase (<a href="#ch28fig1" class="ulink-inter">Fig. 28.1C</a>):</span> Soon, the laminar flow reverses, and the entire blood column in the vein is mixed with the dye.</p></li>
<li><p class=""><span class="italic">Recirculation phase (<a href="#ch28fig1" class="ulink-inter">Fig. 28.1D</a>):</span> This phase is marked by the <span class="italic">eventual fade of the dye</span>. If the blood-retinal barrier has been broken, the dye leaks out and stains the abnormal vessels, or pools into the tissue.</p></li>
<li><p class=""><span class="italic">Normal macula:</span> It appears as a small hypofluorescent area. The perifoveal capillary arcade is seen during venous phase.</p>
<p class=""><span class="italic">Dark appearance of macula is due to:</span></p>
<ul style="list-style-type: square">
<li><p class="">Macular-RPE (retinal pigment epithelium) cells are taller and more pigmented</p></li>
<li><p class="">Presence of xanthophyll pigment</p></li>
<li><p class="">Foveal avascular zone (FAZ)<a name="page565"></a><span class="pageBreak"></span><span class="pageNumbers"><span class="bottomPage">565</span></span></p>
<p class=""><div class="figure" id="ch28fig1" data-label="Figs. 28.1A to D"><div class="title"><span class="item-label">Figs. 28.1A to D</span> Phases of fundus fluorescein angiography. <bold>A.</bold> Arterial; <bold>B.</bold> Early venous; <bold>C.</bold> Late venous; <bold>D.</bold> Recirculation phase.</div><img alt="Figs. 28.1A to D" src="/MediumImage/565-1.jpg"><div class="additional-markup"></div></div></p></li>
</ul></li>
<li><p class=""><span class="italic">Optic disc:</span> The capillary fluorescence is seen at different stages, and valuable in differentiating pseudopapilledema, from papilledema and papillitis.</p></li>
</ul>
<p class="noindent"><span class="italic">After 10 minutes</span>, the fundus resembles that of pre-angiographic state, and any deviation from this is abnormal.</p>
</div>
<div class="section" id="ch28lev3sec11"><h3 class="title">Abnormal Angiogram</h3>
<p class="noindent">It is based on two important features:</p>
<ul style="list-style-type: bullet">
<li><p class="">The blood-retinal barrier</p></li>
<li><p class="">The barrier between choroid and RPE.</p>
<ol style="list-style-type: decimal">
<li><p class=""><span class="italic">Hypofluorescence (<a href="#ch28fig2" class="ulink-inter">Figs. 28.2A and B</a>):</span> It means a reduction or absence of normal fluorescence. It appears as dark area on the positive print of an angiogram.</p>
<p class=""><div class="informaltable"><div class="table-scroll"><table>


<thead>
<tr>
<th colspan="2" class="left"><p class="">Two possible causes of hypofluorescence.</p></th>
</tr>
</thead>
<tbody>
<tr>
<td class="left"><p class=""><span class="italic">Causes</span></p></td>
<td class="left"><p class=""><span class="italic">Example of lesions</span></p></td>
</tr>
<tr>
<td class="left"><p class=""><bold>Blocked fluorescence</bold></p></td>
<td class="left"><p class="">
<ul style="list-style-type: bullet">
<li><p class=""><span class="italic">Pigments</span><span class="italic">—</span>melanin, hemoglobin, xanthophyll</p></li>
<li><p class=""><span class="italic">Exudates</span><span class="italic">—</span>hard, soft</p></li>
<li><p class=""><span class="italic">Hemorrhages</span><span class="italic">—</span>subhyaloid retinal</p></li>
<li><p class="">Abnormal tissue materials—foreign body scar tissue</p></li>
</ul></p></td>
</tr>
<tr>
<td class="left"><p class=""><bold>Vascular filling defects (dropout areas)</bold></p></td>
<td class="left"><p class="">
<ul style="list-style-type: bullet">
<li><p class="">Retinal artery, vein and capillaries, e.g., vascular occlusion</p></li>
<li><p class="">Choriocapillaris, e.g., sclerosis</p></li>
</ul></p></td>
</tr>
</tbody>
</table></div></div></p></li>
<li><p class=""><span class="italic">Hyperfluorescence (<a href="#ch28fig3" class="ulink-inter">Figs. 28.3</a> and <a href="#ch28fig4" class="ulink-inter">28.4</a>):</span> It constitutes the appearance of an area that is more fluorescent than the surrounding area, or that stays fluorescent for a longer period of time.<a name="page566"></a><span class="pageBreak"></span><span class="pageNumbers"><span class="bottomPage">566</span></span></p>
<p class=""><div class="figure" id="ch28fig2" data-label="Figs. 28.2A and B"><div class="title"><span class="item-label">Figs. 28.2A and B</span> <bold>A.</bold> Branch retinal vein occlusion—at the disc margin; <bold>B.</bold> Fundus fluoresce in angiography— same eye showing hypofluorescence.</div><img alt="Figs. 28.2A and B" src="/MediumImage/566-1.jpg"><div class="additional-markup"></div></div></p>
<p class=""><div class="figure" id="ch28fig3" data-label="Figs. 28.3A and B"><div class="title"><span class="item-label">Figs. 28.3A and B</span> <bold>A.</bold> Hard and calcified drusen; <bold>B.</bold> Fundus fluorescein angiography—same eye showing hyperfluorescence.</div><img alt="Figs. 28.3A and B" src="/MediumImage/566-2.jpg"><div class="additional-markup"></div></div></p>
<p class=""><div class="figure" id="ch28fig4" data-label="Figs. 28.4A and B"><div class="title"><span class="item-label">Figs. 28.4A and B</span> <bold>A.</bold> Proliferative diabetic retinopathy; <bold>B.</bold> Fundus fluorescein angiography—both same eye showing hypo- and hyperfluorescence area, or that stays fluorescent for a longer period of time.</div><img alt="Figs. 28.4A and B" src="/MediumImage/566-3.jpg"><div class="additional-markup"></div></div></p>
<p class=""><a name="page567"></a><span class="pageBreak"></span><span class="pageNumbers"><span class="bottomPage">567</span></span></p>
<p class=""><div class="informaltable"><div class="table-scroll"><table>


<tbody>
<tr>
<td colspan="2" class="left"><p class="">Three possible causes of hyperfluorescence.</p></td>
</tr>
<tr>
<td class="left"><p class=""><span class="italic">Causes</span></p></td>
<td class="left"><p class=""><span class="italic">Example of lesions</span></p></td>
</tr>
<tr>
<td class="left"><p class=""><bold>Increased transmission</bold></p></td>
<td class="left"><p class="">
<ul style="list-style-type: bullet">
<li><p class=""><span class="italic">Atrophic:</span> RPE—drusen, RPE-window defect</p></li>
</ul></p></td>
</tr>
<tr>
<td class="left"><p class=""><bold>Leak</bold></p></td>
<td class="left"><p class="">
<ul style="list-style-type: bullet">
<li><p class=""><span class="italic">Pooling</span> (in spaces)
<ul style="list-style-type: dash">
<li><p class=""><span class="italic">Retinal:</span> CME</p></li>
<li><p class=""><span class="italic">Subretinal:</span> CSR, RD</p></li>
</ul></p></li>
<li><p class=""><span class="italic">Staining</span> (of tissues)
<ul style="list-style-type: dash">
<li><p class=""><span class="italic">Retinal</span>—soft exudates</p></li>
<li><p class=""><span class="italic">Subretinal</span>—drusen, scar</p></li>
</ul></p></li>
</ul></p></td>
</tr>
<tr>
<td class="left"><p class=""><bold>Abnormal vessels</bold></p></td>
<td class="left"><p class="">
<ul style="list-style-type: bullet">
<li><p class=""><span class="italic">Retinal</span>—neovascularization, aneurysms, shunts, collaterals, telangiectasis</p></li>
<li><p class=""><span class="italic">Subretinal</span>—SRNVMs, vessels in scar</p></li>
<li><p class=""><span class="italic">Tumors</span>
<ul style="list-style-type: dash">
<li><p class=""><span class="italic">Retinal</span>—retinoblastoma</p></li>
<li><p class=""><span class="italic">Subretinal</span>—malignant melanoma, choroidal hemangioma</p></li>
</ul></p></li>
</ul></p></td>
</tr>
<tr>
<td colspan="2" class="left"><p class="small"><bold>RPE—</bold>Retinal pigmented epithelium; <bold>CME—</bold>Cystoid macular edema; <bold>CSR—</bold>Central serous retinopathy; <bold>RD—</bold>Retinal detachment; <bold>SRNVMs—</bold> Subretinal neovascular membranes</p></td>
</tr>
</tbody>
</table></div></div></p></li>
</ol></li>
</ul>
<p class="noindent">Fundus fluorescein angiography (FFA) is useful as an important diagnostic tool for certain clinical conditions. It is also important to monitor laser photocoagulation treatment, in certain retina and choroidal diseases.</p>
<p class="noindent"><span class="italic">The common indications are:</span></p>
<ul style="list-style-type: bullet">
<li><p class="">Diabetic retinopathy</p></li>
<li><p class="">Retinal venous occlusions (CRVO or BRVO)</p></li>
<li><p class="">Eales’ disease</p></li>
<li><p class="">Central serous retinopathy (CSR)</p></li>
<li><p class="">Age-related macular degeneration</p></li>
<li><p class="">Tumors of the retina and choroid</p></li>
<li><p class="">Vascular anomalies of the retina and choroid</p></li>
<li><p class="">Papilledema</p></li>
</ul>
</div>
</div>
<div class="section" id="ch28lev2sec13"><h2 class="title">Fundus Autofluorescence</h2>
<ul style="list-style-type: bullet">
<li><p class="">Fundus autofluorescence (FAF) is the emission of fluorescent light from ocular structures in the absence of sodium fluorescein. Pseudofluorescence occurs when the blue exciter and green barrier filters overlap.</p></li>
<li><p class="">Retinal pigmented epithelium (RPE) is a monolayer which plays a critical role in phagocytosis and lysosomal breakdown of pigmented outer segments of photoreceptors. With aging, incomplete or partial breakdown of these segments in the postmitotic RPE cells causes the accumulation of lipofuscin. Excessive lipofuscin deposition is considered pathologic and is associated with visual loss.</p></li>
<li><p class="">Because of its diverse composition, lipofuscin has a broad-spectrum of excitation (300–600 nm) and emission (480–800 nm). Thus, it can be excited by many wavelengths of visible light in the blue and green portion of spectrum. Autofluorescence uses the fluorescent properties of lipofuscin to generate images.</p></li>
<li><p class="">The unique autofluorescent properties of RPE lipofuscin can be detected and quantified using imaging devices like, confocal scanning laser ophthalmoscope (cSLO) and FAF camera systems.</p></li>
<li><p class="">Fundus autofluorescence imaging has potential role to provide useful information in conditions where the health of the RPE plays a key role <bold>(<a href="#ch28fig5" class="ulink-inter">Figs. 28.5A to D</a>)</bold>.</p></li>
</ul>
<p class="noindent"><span class="italic">Reduced fundus autofluorescence:</span></p>
<ul style="list-style-type: bullet">
<li><p class="">Retinal pigmented epithelium loss or atrophy</p></li>
<li><p class="">Intraretinal fluid</p></li>
<li><p class="">Reduction in RPE lipofuscin density</p></li>
<li><p class="">Fibrosis</p></li>
<li><p class="">Presence of luteal pigment.</p></li>
</ul>
<p class="noindent"><span class="italic">Increased fundus autofluorescence:</span></p>
<ul style="list-style-type: bullet">
<li><p class="">Drusen</p></li>
<li><p class="">Excessive RPE lipofuscin accumulation</p></li>
<li><p class="">Age-related macular degeneration.</p></li>
</ul>
<p class="noindent"><span class="italic">Fundus autofluorescence is useful in the diagnosis of:</span></p>
<ul style="list-style-type: bullet">
<li><p class="">Age-related macular degeneration</p></li>
<li><p class="">Retinitis pigmentosa<a name="page568"></a><span class="pageBreak"></span><span class="pageNumbers"><span class="bottomPage">568</span></span></p></li>
</ul>
<div class="figure" id="ch28fig5" data-label="Figs. 28.5A to D"><div class="title"><span class="item-label">Figs. 28.5A to D</span> Fundus autofluorescence showing heredo-macular dystrophy. <bold>A and B.</bold> Fundus as seen in normal digital fundus photography; <bold>C and D.</bold> Same eyes with FAF camera system.</div><img alt="Figs. 28.5A to D" src="/MediumImage/568-1.jpg"><div class="additional-markup"></div></div>
<ul style="list-style-type: bullet">
<li><p class="">White dot syndromes</p></li>
<li><p class="">Central serous chorioretinopathy</p></li>
<li><p class="">Macular dystrophies like—Stargardt disease, cone dystrophies, and Best's disease</p></li>
<li><p class="">Chloroquine maculopathy.</p></li>
</ul>
</div>
<div class="section" id="ch28lev2sec14"><h2 class="title">Indocyanine Green Angiography</h2>
<p class="noindent">Indocyanine green angiography (ICGA) is a diagnostic technique that uses ICG dye's infrared fluorescence to provide details about the choroidal circulation and its disorders <bold>(<a href="#ch28fig6" class="ulink-inter">Figs. 28.6A to D</a>)</bold>.</p>
<ul style="list-style-type: bullet">
<li><p class="">Indocyanine green angiography is an amphophilic tricarbocyanine dye and the lyophilized powder is dissolved in water for injection. It is 98% bound to proteins and remains longer in large blood vessels with a lesser tendency to diffuse in the interstitial space. Hence, it is ideal for diseases affecting the choroidal tissues.</p></li>
<li><p class="">Plasma half-life of ICG is 2–4 minutes. Maximal peak of absorption is at 790–805 nm and a peak emission of 835 nm.</p></li>
<li><p class="">There are two types of ICG systems—modified fundus cameras and SLO-based systems. Dosage of dye varies from 20 mg to 50 mg dissolved in 2–4 mL of aqueous solvent. Preferred technique is to inject 25 mg dye in 5 mL of water slowly.</p></li>
<li><p class="">Some iodine is present in the dye and cross over allergy can occur. Contraindications are prior anaphylactic reactions to iodinebased preparations, hepatic insufficiency, uremia and pregnancy.</p></li>
</ul>
</div>
<div class="section" id="ch28lev2sec15"><h2 class="title">Phases</h2>
<ul style="list-style-type: bullet">
<li><p class=""><span class="italic">Early phase:</span> It occurs 2 seconds after injection of ICG, choroidal arteries and choriocapillaris fills up, 3–5 seconds after injection, larger choroidal veins begin to fill.<a name="page569"></a><span class="pageBreak"></span><span class="pageNumbers"><span class="bottomPage">569</span></span></p></li>
</ul>
<div class="figure" id="ch28fig6" data-label="Figs. 28.6A to D"><div class="title"><span class="item-label">Figs. 28.6A to D</span> Indocyanine green angiography (ICGA). <bold>A.</bold> Digital fundus photograph of a case of occult choroidal neovascular membrane (CNVM); <bold>B.</bold> Same lesion as visible under autofluorescence; <bold>C.</bold> Same lesion as seen in fundus fluorescence angiography; <bold>D.</bold> Same lesion best visible in ICGA (white arrows).</div><img alt="Figs. 28.6A to D" src="/MediumImage/569-1.jpg"><div class="additional-markup"></div></div>
<ul style="list-style-type: bullet">
<li><p class=""><span class="italic">Middle phase:</span> It occurs at 3–15 minutes after injection and marked by continuous fading of choroidal and retinal vessels.</p></li>
<li><p class=""><span class="italic">Late phase:</span> It occurs at 15–60 minutes after injection.</p></li>
</ul>
<p class="indent">Abnormal areas can be described as hypocyanescence or hypercyanescence.</p>
<div class="section" id="ch28lev3sec12"><h3 class="title">Hypocyanescence</h3>
<p class="noindent">Blockage—blood/serous fluid/pigment/exudates/impaired choroidal perfusion.</p>
</div>
<div class="section" id="ch28lev3sec13"><h3 class="title">Hypercyanescence</h3>
<ul style="list-style-type: bullet">
<li><p class="">Lack of overlying tissue—RPE dropout/lacquer cracks</p></li>
<li><p class="">Leakage from surrounding vessels</p></li>
<li><p class="">Leakage from abnormal blood vessels
<ul style="list-style-type: square">
<li><p class="">Hot spots and plaques are used to define areas of intense hyperfluorescence during the middle and late phases.</p></li>
<li><p class="">Hot spots are defined as &lt;1 DD (disc diameter) in size. Plaques are &gt;1 DD in size and reveal less obvious leakage.</p></li>
</ul></p></li>
</ul>
</div>
</div>
</div><div class="section" id="ch28lev1sec4"><h1 class="title">ULTRASONOGRAPHY IN OPHTHALMOLOGY</h1>
<p class="noindent">Sound frequencies between 16 Hz and 20,000 Hz are audible, and frequencies above 20,000 Hz are called ultrasound.<a name="page570"></a><span class="pageBreak"></span><span class="pageNumbers"><span class="bottomPage">570</span></span></p>
<p class="indent">The ultrasound is reflected toward its source, when it encounters a change in elasticity or density of the medium through which it is passing. This reflected vibration <span class="italic">(echo)</span> is converted into an electric potential by a <span class="italic">piezoelectric crystal,</span> and displayed on an oscilloscope.</p>
<p class="indent">Ultrasonic frequencies in the range of 10 MHz are used in ophthalmic ultrasonography (USG). <span class="italic">Two types of USG are used: A-scan and B-scan.</span></p>
<div class="section" id="ch28lev2sec16"><h2 class="title">Ultrasonography A-scan (<a href="#ch28fig7" class="ulink-inter">Fig. 28.7</a>)</h2>
<p class="noindent">A transducer is positioned so that the ultrasonic beam passes through a chosen ocular meridian. The tracing records a series of spikes, at sites of change in intraocular impedance. The <span class="italic">height of each spike</span> depends on the acoustic density of the tissue, which varies with cellular composition. <span class="italic">The distance</span> between the spikes gives a measure of the distance from the transducer as well as distance between intraocular structures. A-scan is <span class="italic">one-dimensional</span>, and hence, amplitude modulated display provides the information. A-scan may be axial or nonaxial <span class="italic">(di-scleral)</span> <bold>(<a href="#ch28fig8" class="ulink-inter">Figs. 28.8A and B</a>)</bold>.</p>
<div class="figure" id="ch28fig7" data-label="Fig. 28.7"><div class="title"><span class="item-label">Fig. 28.7</span> A-scan ultrasonography.</div><img alt="Fig. 28.7" src="/MediumImage/570-1.jpg"><div class="additional-markup"></div></div>
<div class="section" id="ch28lev3sec14"><h3 class="title">Uses of A-scan</h3>
<ul style="list-style-type: bullet">
<li><p class="">Axial length measurement for intraocular lens power calculation.</p></li>
<li><p class="">Measurement of anterior chamber depth, lens thickness, or depth of a lesion.</p></li>
<li><p class="">To detect pathological lesions preoperatively, in presence of opacities in the ocular media.</p></li>
<li><p class="">To differentiate a preretinal membrane from a retinal detachment <span class="italic">(quantitative echography)</span>.</p></li>
<li><p class="">To differentiate between benign and malignant intraocular lesions.</p></li>
<li><p class="">To measure corneal thickness <span class="italic">(ultrasonic pachymetry)</span> before radial keratotomy operation, or PRK or LASIK.</p></li>
</ul>
<div class="figure" id="ch28fig8" data-label="Figs. 28.8A and B"><div class="title"><span class="item-label">Figs. 28.8A and B</span> Ultrasonography A-scan. <bold>A.</bold> Normal spikes in normal eye; <bold>B.</bold> Abnormal spikes in vitreous chamber indicating vitreous hemorrhage with retino-choroidal detachment.</div><img alt="Figs. 28.8A and B" src="/MediumImage/570-2.jpg"><div class="additional-markup"></div></div>
<p class=""><a name="page571"></a><span class="pageBreak"></span><span class="pageNumbers"><span class="bottomPage">571</span></span></p>
<div class="figure" id="ch28fig9" data-label="Fig. 28.9"><div class="title"><span class="item-label">Fig. 28.9</span> B-scan ultrasonography.</div><img alt="Fig. 28.9" src="/MediumImage/571-1.jpg"><div class="additional-markup"></div></div>
</div>
</div>
<div class="section" id="ch28lev2sec17"><h2 class="title">Ultrasonography B-scan (<a href="#ch28fig9" class="ulink-inter">Fig. 28.9</a>)</h2>
<p class="noindent">The testing transducer is moved in a linear fashion across the eye, to build up a <span class="italic">two-dimensional</span> picture of the intraocular structures, and the orbit.</p>
<p class="indent">Echoes are plotted as <span class="italic">dots</span> instead of spikes, and the brightness of the dot indicates the size of the received echoes. The resulting B-scan picture is comparable to a histological crosssection through the eye and the orbit. B-scan may be taken on the sagittal, horizontal or oblique planes of the eye.</p>
<div class="section" id="ch28lev3sec15"><h3 class="title">Uses of B-scan (<a href="#ch28fig10" class="ulink-inter">Figs. 28.10A and B</a>)</h3>
<ul style="list-style-type: bullet">
<li><p class="">To differentiate the space-occupying lesions within the eye and the orbit.</p></li>
<li><p class="">To determine the vitreoretinal pathology (e.g., retinal detachment, or vitreous hemorrhage) in presence of opacity in the ocular media.</p></li>
<li><p class="">To localize the intraocular foreign body, especially, if it is not radiopaque.</p></li>
<li><p class="">To study the muscle thickness, e.g., in thyroid ophthalmopathy or orbital pseudotumor.</p></li>
<li><p class="">To study the vitreous hemorrhage and its complications (e.g., vitreous bands) prior to vitreous surgery.</p></li>
<li><p class="">To differentiate the types of retinal detachment (e.g., rhegmatogenous, exudative or tractional).</p></li>
</ul>
</div>
</div>
</div><div class="section" id="ch28lev1sec5"><h1 class="title">ULTRASOUND BIOMICROSCOPY</h1>
<p class="noindent">It is a ultrasound guided diagnostic tool which allows detailed imaging of the anterior segment of the eye <span class="italic">(like slit-lamp biomicroscopy)</span>.</p>
<p class="indent">High-frequency, high-resolution ultrasound biomicroscopy (UBM) is similar in principle to conventional USG B-scan.</p>
<div class="figure" id="ch28fig10" data-label="Figs. 28.10A and B"><div class="title"><span class="item-label">Figs. 28.10A and B</span> <bold>A.</bold> Normal USG-B scan; <bold>B.</bold> Abnormal membrane (spikes) in front of lower retina indicating inferior retinal detachment.</div><img alt="Figs. 28.10A and B" src="/MediumImage/571-2.jpg"><div class="additional-markup"></div></div>
<p class="indent"><a name="page572"></a><span class="pageBreak"></span><span class="pageNumbers"><span class="bottomPage">572</span></span>In general, the resolution and depth of penetration of ultrasound waves are affected by transducer frequency.</p>
<p class="indent">The ocular USG B-scan uses a 10 MHz transducer, with approximately 150 µm resolution.</p>
<p class="noindent">Whereas, an UBM is performed with a <span class="italic">high frequency (50 MHz)</span> transducer with a tissue resolution of 50 µm. But this is at the expense of decreasing tissue penetration depth of 4–5 mm which is sufficient to image the anterior segment <bold>(<a href="#ch28fig11" class="ulink-inter">Figs. 28.11A and B</a>)</bold>.</p>
<p class="indent">Ultrasound scanning of the cornea is possible with a 100 MHz transducer that increases the tissue resolution to less than 20 µm.</p>
<div class="section" id="ch28lev2sec18"><h2 class="title">Uses</h2>
<ul style="list-style-type: bullet">
<li><p class="">High frequency UBM allows detailed imaging of the:
<ul style="list-style-type: square">
<li><p class="">Anterior segment of the eye</p></li>
<li><p class="">Angle of the anterior chamber <bold>(<a href="#ch28fig11" class="ulink-inter">Figs. 28.11A and B</a>)</bold></p></li>
<li><p class="">Ciliary body (e.g., tumor, etc.)</p></li>
<li><p class="">Pars plana and peripheral vitreous (e.g., pars planitis).</p></li>
</ul></p></li>
<li><p class="">It also helps to identify position of intraocular lens and its haptics.</p></li>
</ul>
<p class="noindent"><span class="italic">Advantage of UBM:</span> To assess the above structures in patients with media opacity—like, edematous or scarred corneal tissue.</p>
</div>
</div><div class="section" id="ch28lev1sec6"><h1 class="title">RADIOLOGY IN OPHTHALMOLOGY</h1>
<p class="noindent">Each orbit is a four-sided pyramidal cavity with apex aimed posteromedially and the base toward the face. It is made up of <span class="italic">parts of seven bones</span> and divided into the roof, medial wall, lateral wall and the floor. Radiological examination of the eye and orbit is useful for evaluating trauma, foreign body, and tumors.</p>
<div class="section" id="ch28lev2sec19"><h2 class="title">X-ray</h2>
<p class="noindent">X-ray studies of the orbits are difficult because of superimposition of the other bones of the skull. The patient is placed on the radiographic table, usually in the prone position.</p>
<p class="indent">Several techniques are used to localize lesions at a particular depth and side:</p>
<ul style="list-style-type: bullet">
<li><p class=""><span class="italic">Caldwell's view</span> is a PA projection of the orbit. This is important for orbital rim, roof, and superior orbital fissure.</p></li>
<li><p class=""><span class="italic">Water's view</span> is useful for orbital floor.</p></li>
<li><p class=""><span class="italic">Rheese view</span> is useful for optic canal.</p></li>
<li><p class=""><span class="italic">Oblique view</span> is especially useful for orbital rim fracture.</p></li>
<li><p class=""><span class="italic">Lateral view</span> is useful for localization of foreign bodies.</p></li>
<li><p class=""><span class="italic">X-ray orbit with limbal marker</span> to localize intraocular metallic foreign body more precisely in relation to the limbus.</p></li>
</ul>
<div class="figure" id="ch28fig11" data-label="Figs. 28.11A and B"><div class="title"><span class="item-label">Figs. 28.11A and B</span> UBM of anterior chamber angle. <bold>A.</bold> Normal angle; <bold>B.</bold> Angle in pupillary block.</div><img alt="Figs. 28.11A and B" src="/MediumImage/572-1.jpg"><div class="additional-markup"></div></div>
<ul style="list-style-type: bullet">
<li><p class=""><a name="page573"></a><span class="pageBreak"></span><span class="pageNumbers"><span class="bottomPage">573</span></span><span class="italic">Dacryocystography</span> is an X-ray evaluation of the drainage system of lacrimal apparatus in an attempt to localize the precise site of obstruction.</p></li>
<li><p class=""><span class="italic">Orbital venography</span> is an X-ray evaluation of the orbital veins with a contrast dye to diagnose orbital varix in case of proptosis.</p></li>
</ul>
</div>
<div class="section" id="ch28lev2sec20"><h2 class="title">CT Scan</h2>
<p class="noindent">The CT scan is the study of choice for soft tissue and bony abnormalities. The main diagnosis possible with CT scan is the orbital tumors. The other diagnosis possible with CT scan includes:</p>
<ul style="list-style-type: bullet">
<li><p class="">Ruptured globe</p></li>
<li><p class="">Intraocular or intraorbital foreign body</p></li>
<li><p class="">Ocular tumors</p></li>
<li><p class="">Fracture of any wall including blowout fracture</p></li>
<li><p class="">Secondary sinus involvement</p></li>
<li><p class="">Neuro-ophthalmological diseases.</p></li>
</ul>
</div>
<div class="section" id="ch28lev2sec21"><h2 class="title">Magnetic Resonance Imaging</h2>
<p class="noindent">Magnetic resonance imaging (MRI) is the procedure of choice for soft tissue anatomy and pathology of vascularized lesions of ocular, orbital and neuro-ophthalmic structures from the orbit to the brain. MRI is also useful in early diagnosis of multiple sclerosis.</p>
</div>
<div class="section" id="ch28lev2sec22"><h2 class="title">Magnetic Resonance Angiography</h2>
<p class="noindent">It is a noninvasive method for imaging the carotid and major cerebral arteries, helpful for neuro-ophthalmologic diagnosis, like carotid artery occlusion/stenosis, any aneurysm, arteriovenous malformation, vascular mass, etc.</p>
</div>
</div><div class="section" id="ch28lev1sec7"><h1 class="title">OCULAR EMERGENCIES</h1>
<p class="noindent">Ocular emergencies are those situations that require immediate attention and management should start within minutes. The following situations need emergency care of the patients:</p>
<ul style="list-style-type: bullet">
<li><p class=""><span class="italic">Chemical burns:</span> Alkali, acid or organic solvents in the eye.</p></li>
<li><p class=""><span class="italic">Sudden painless total loss of vision:</span> This problem suggests an acute vascular occlusion and could cause permanent loss of vision if not treated immediately, especially in central retinal arterial occlusion (CRAO).</p></li>
</ul>
<p class="indent"><span class="italic">Above two conditions need real emergency management without any delay.</span></p>
<p class="noindent"><span class="italic">Others are:</span></p>
<ul style="list-style-type: bullet">
<li><p class=""><span class="italic">Open globe injury</span> of the eyeball.</p></li>
<li><p class=""><span class="italic">Severe blunt trauma</span> such as a forceful blow to the eyeball with a fist or by a cricket or tennis ball.</p></li>
<li><p class=""><span class="italic">A foreign body</span> in the eye.</p></li>
<li><p class=""><span class="italic">Corneal abrasion</span> caused by a foreign body or by trauma.</p></li>
<li><p class=""><span class="italic">Sudden painless severe dimness of vision</span>—as in optic neuritis or retinal detachment.</p></li>
<li><p class=""><span class="italic">Acute painful red eye with loss of vision</span>, e.g., acute attack of angle closure glaucoma, lens-induced glaucoma, etc.</p></li>
<li><p class=""><span class="italic">Any emergency referral</span> from other physician or ophthalmologist.</p></li>
</ul>
<div class="section" id="ch28lev2sec23"><h2 class="title">Ocular Urgent Situations</h2>
<p class="noindent">The urgent situation requires the patient should be seen within 24–72 hours. The patients with urgent conditions may report with a variety of symptoms, some of which may suggest an emergency situation, while the others, although not serious, but may deserve prompt attention. <span class="italic">Sometimes, it is difficult to distinguish an urgent situation from an emergency.</span></p>
<p class="indent">The following situations are generally considered to be urgent:</p>
<ul style="list-style-type: bullet">
<li><p class="">Subacute or gradual loss of vision over a few days to a week</p></li>
<li><p class="">Sudden onset of diplopia</p></li>
<li><p class="">Recent onset of flashes and floaters especially in myopes</p></li>
<li><p class="">Acute red eye with/without discharge and loss of vision</p></li>
<li><p class="">Acute and progressively increasing ocular pain</p></li>
<li><p class="">Sudden onset of photophobia</p></li>
<li><p class="">Graft rejection-in any type of keratoplasty<a name="page574"></a><span class="pageBreak"></span><span class="pageNumbers"><span class="bottomPage">574</span></span></p></li>
<li><p class="">Loss or breakage of glasses or contact lenses needed for work, driving or studies (though not all physicians consider losing or breaking glasses as urgent).</p></li>
</ul>
</div>
</div><div class="section" id="ch28lev1sec8"><h1 class="title">SUBCONJUNCTIVAL INJECTION</h1>
<p class="noindent">Subconjunctival injections are most useful for attaining effective concentration of drugs in the aqueous. Though, in most cases they can be replaced by frequent topical application of drugs.</p>
<p class="indent"><span class="italic">Routes of absorption of drugs after subconjunctival injection:</span></p>
<ul style="list-style-type: bullet">
<li><p class="">Part of the effects of a subconjunctival injection is due to gradual reflux of the drug along with the needle track, with subsequent transcorneal absorption.</p></li>
<li><p class="">Partly, via the sclera adjacent to the injection site.</p></li>
</ul>
<div class="section" id="ch28lev2sec24"><h2 class="title">Disadvantages</h2>
<ul style="list-style-type: bullet">
<li><p class="">These injections may be painful, especially in case of inflamed eyes.</p></li>
<li><p class="">Conjunctiva tends to become scarred.</p></li>
<li><p class="">Accidental globe perforation may occur which is dangerous.</p></li>
</ul>
</div>
<div class="section" id="ch28lev2sec25"><h2 class="title">Indications</h2>
<ul style="list-style-type: bullet">
<li><p class="">Severe ocular infections, e.g., in bacterial corneal ulcers (mainly antibiotic and atropine).</p></li>
<li><p class="">Severe intraocular inflammation, e.g., iridocyclitis (steroids and atropine) or endophthalmitis (antibiotics and atropine).</p></li>
<li><p class="">At the end of any intraocular surgery, e.g., after cataract operation or penetrating keratoplasty (gentamicin and dexamethasone).</p></li>
<li><p class="">To give subconjunctival anesthesia in certain operations, e.g., pterygium resection, or to remove a conjunctival cyst or mass.</p></li>
</ul>
</div>
<div class="section" id="ch28lev2sec26"><h2 class="title">Procedure</h2>
<ol style="list-style-type: lower-roman">
<li><p class="">Topical anesthesia by 4% lignocaine or 0.5% proparacaine. A small cotton palette soaked in anesthetic agent is held on the area for 2 minutes—very effective.</p></li>
<li><p class="">Patient is lying on a bed.</p></li>
<li><p class="">Care has to taken to minimize patient's apprehension.</p></li>
<li><p class="">Wire speculum is applied.</p></li>
<li><p class="">Patient is asked to look upward or opposite side away from the site of injection.</p></li>
<li><p class="">0.5−1 mL of drug is taken in a 1 or 2 mL syringe with 26 or 30 G needle or (in an insulin syringe).</p></li>
<li><p class="">Gently hold a fold of conjunctiva in a tent fashion, 3 mm away from the limbus with a plain forceps, avoiding the blood vessels.</p></li>
<li><p class="">The needle tip with beveled up, is slid underneath the bulbar conjunctiva. The plunger of the syringe is withdrawn to ensure against any intravascular penetration.</p></li>
<li><p class="">Inject about 0.5 mL solution at a time.</p></li>
<li><p class="">Gently withdraw the needle.</p></li>
<li><p class="">Cover the eye with a pad for 1 hour.</p></li>
</ol>
</div>
</div><div class="section" id="ch28lev1sec9"><h1 class="title">SUB-TENON INJECTION</h1>
<p class="noindent">Here, the main route of absorption is via the trans-scleral route near the injection site. Posterior sub-Tenon injection is mostly preferred.</p>
<p class="indent">This is the most effective method of continuous drug delivery, especially in inflamed eyes. The most popular drug used for sub-Tenon injection is depot steroids, e.g., triamcinolone or methylprednisolone with or without atropine and antibiotic.</p>
<p class="noindent"><span class="italic">Indication:</span> Chronic uveitis (pars planitis and posterior uveitis) and cystoid macular edema (CME).</p>
<p class="noindent"><span class="italic">Best site of injection:</span> Upper temporal quadrant. Alternately, the inferotemporal quadrant may be selected for injection.</p>
<div class="section" id="ch28lev2sec27"><h2 class="title">Procedure</h2>
<p class="noindent">Step (i) to (v) same as subconjunctival injection.</p>
<ul style="list-style-type: bullet">
<li><p class="">Patient is instructed to look down and in, toward his nose.</p></li>
<li><p class="">With the beveled side toward the globe, the needle is introduced into the superior <a name="page575"></a><span class="pageBreak"></span><span class="pageNumbers"><span class="bottomPage">575</span></span>bulbar conjunctival area avoiding the conjunctival blood vessels and moved from side to side and injected deep into the posterior sub-Tenon's space.</p></li>
</ul>
<div class="section" id="ch28lev3sec16"><h3 class="title">Disadvantages</h3>
<ul style="list-style-type: bullet">
<li><p class="">It is technically difficult.</p></li>
<li><p class="">Chance of globe perforation is more than subconjunctival injection.</p></li>
<li><p class="">Steroid-induced glaucoma which is difficult to manage. May have to dissect sub-Tenon space and remove the depot steroids.</p></li>
</ul>
</div>
</div>
</div><div class="section" id="ch28lev1sec10"><h1 class="title">INTRAVITREAL INJECTIONS</h1>
<p class="noindent">Injecting drugs directly into the vitreous cavity is indicated in various posterior segment pathologies. This route delivers the drugs at the target site and bypasses all absorption barriers. The gel-like vitreous also acts as a reservoir for the drug which acts slowly over time. Some patients may require multiple injections.</p>
<p class="noindent"><span class="italic">Indications of intravitreal injections:</span></p>
<ul style="list-style-type: bullet">
<li><p class="">Various drug delivery</p></li>
<li><p class="">Vitreous biopsy/tap for microbiology (smear, culture or PCR).</p></li>
</ul>
<p class="noindent"><span class="italic">The various drugs given intravitreally are:</span></p>
<div class="informaltable"><div class="table-scroll"><table>



<thead>
<tr>
<th class="left"><p class=""><span class="italic">Drug group</span></p></th>
<th class="left"><p class=""><span class="italic">Indications</span></p></th>
<th class="left"><p class=""><span class="italic">Drugs</span></p></th>
</tr>
</thead>
<tbody>
<tr>
<td class="left"><p class="">Antibiotics</p></td>
<td class="left"><p class="">Endophthalmitis</p></td>
<td class="left"><p class="">Vancomycin, Ceftazidime, Amikacin</p></td>
</tr>
<tr>
<td class="left"><p class="">Antifungals</p></td>
<td class="left"><p class="">Endophthalmitis</p></td>
<td class="left"><p class="">Amphotericin B, Voriconazole</p></td>
</tr>
<tr>
<td class="left"><p class="">Antivirals</p></td>
<td class="left"><p class="">Viral retinal necrosis or retinopathy</p></td>
<td class="left"><p class="">Ganciclovir, Foscarnet</p></td>
</tr>
<tr>
<td class="left"><p class="">Anti-VEGFs</p></td>
<td class="left"><p class="">Diabetic retinopathy, Wet ARMD, ROP</p></td>
<td class="left"><p class="">Ranibizumab, Bevacizumab, Aflibercept</p>
<p class="">Brolucizumab</p>
<p class="">Farcizumab</p></td>
</tr>
<tr>
<td class="left"><p class="">Steroid*</p></td>
<td class="left"><p class="">CME in BRVO or chronic uveitis</p></td>
<td class="left"><p class="">Triamcinolone acetonide</p></td>
</tr>
<tr>
<td colspan="3" class="left"><p class="small">*Steroids are sometimes administered as slow-release implants for prolonged duration of action. The commonly used implants are: Dexamethasone implant—Ozurdex; and Fluocinolone implant—Retisert and Iluvien.</p></td>
</tr>
</tbody>
</table></div></div>
<p class="noindent"><span class="italic">Procedure:</span></p>
<ul style="list-style-type: bullet">
<li><p class="">Done usually under topical anesthesia (paracaine or lignocaine)</p></li>
<li><p class="">Instil drop of <span class="italic">povidone iodine 5%</span> in conjunctival sac</p></li>
<li><p class="">Insert eye speculum for exposure</p></li>
<li><p class=""><span class="italic">Pre-injection dilation</span> is helpful as the needle tip can be visualized during injection</p></li>
<li><p class=""><span class="italic">Needle used:</span> 30 G; volume injected 0.05 to 0.1 mL</p></li>
<li><p class=""><span class="italic">Injection location:</span> Commonly in inferotemporal region for ease of access (sometimes superotemporal)</p></li>
<li><p class=""><span class="italic">Measure injection site location from limbus with calipers:</span> 3 mm in aphakia, 3.5 mm in pseudophakia, and 4 mm in phakic eyes</p></li>
<li><p class="">Needle direction is toward center of globe. Nowadays usually a straight needle path is followed.</p></li>
<li><p class="">A sterile cotton swab is placed at injection site immediately after withdrawing needle to prevent reflux.</p></li>
<li><p class="">Post-procedure topical antibiotics are given for 5−7 days.</p></li>
</ul>
<p class="noindent"><span class="italic">Complications:</span> Transient rise in IOP; acute rise in IOP causing central retinal artery occlusion (CRAO); retinal or vitreous hemorrhage; retinal detachment, and endophthalmitis.</p>
</div><div class="section" id="ch28lev1sec11"><h1 class="title">LABORATORY DIAGNOSIS OF OCULAR INFECTIONS</h1>
<div class="section" id="ch28lev2sec28"><h2 class="title">Conjunctival Swab</h2>
<p class="noindent">Laboratory diagnosis in bacterial conjunctivitis is not a routine. However, the <span class="italic">indications</span> of conjunctival scraping for microscopic examination are:</p>
<ul style="list-style-type: bullet">
<li><p class="">Neonatal conjunctivitis</p></li>
<li><p class="">Hyperacute purulent conjunctivitis</p></li>
<li><p class="">Chronic recalcitrant conjunctivitis. Conjunctival swab is a routine procedure before any intraocular operation (e.g., cataract operation, glaucoma operation) in some places. But it is not a mandatory.<a name="page576"></a><span class="pageBreak"></span><span class="pageNumbers"><span class="bottomPage">576</span></span></p></li>
</ul>
<div class="section" id="ch28lev3sec17"><h3 class="title">Methods</h3>
<ul style="list-style-type: bullet">
<li><p class="">Conjunctival scrapings should be taken prior to the use of topical anesthetics, as these agents and their preservatives may mask the recovery of certain bacteriae.</p></li>
<li><p class="">Cultures are taken by moisturizing a sterile alginate (not cotton) swab with saline and wiping the inner lid margin or conjunctival cul-de-sac.</p></li>
<li><p class="">They are then inoculated in solid or liquid culture media (blood agar and/or chocolate agar).</p></li>
<li><p class="">Simultaneous smear may be prepared for staining with Gram or Giemsa stain. This is to identify the organisms and inflammatory cell types. The cytologic features of each type of conjunctivitis are different and helpful in diagnosis.</p></li>
</ul>
</div>
</div>
<div class="section" id="ch28lev2sec29"><h2 class="title">Corneal Scraping</h2>
<p class="noindent">This is the most important step in early diagnosis of a corneal ulcer, for prompt and rigorous initiation of therapy.</p>
<ul style="list-style-type: bullet">
<li><p class="">The scraping is performed after instillation of topical preservative-free anesthetic agents (e.g., proparacaine 0.5% or lignocaine 2–4%).</p></li>
<li><p class="">The procedure should obtain as much material as feasible, particularly from the deeper areas (floor) and the margins of the ulcer.</p></li>
<li><p class="">Scraping material is usually taken with a No. 15 blade or a Kimura's spatula.</p></li>
<li><p class="">Smear is prepared for microscopic examination with KOH mount, Gram or Giemsa stain. In 30−40% cases in results may be negative for bacteria even if infection is present.</p></li>
<li><p class="">Culture should be done on blood agar plate (at room temperature) and Sabouraud's media (for fungus) and into Page's medium (for acanthamoeba), if suspected.</p></li>
</ul>
</div>
<div class="section" id="ch28lev2sec30"><h2 class="title">Aqueous or Vitreous Tap</h2>
<p class="noindent">In suspected cases of infective endophthalmitis—to find out the causative agent.</p>
</div>
</div><div class="section" id="ch28lev1sec12"><h1 class="title">CORNEAL TOPOGRAPHY (<a href="#ch28fig12" class="ulink-inter">FIGS. 28.12A AND B</a>)</h1>
<p class="noindent">It is a method of qualitative and quantitative evaluation of the corneal surface by the reflected light.</p>
<ul style="list-style-type: bullet">
<li><p class="">In 1619, Father Scheiner first found that corneal surface can be studied from reflection of a window on it <span class="italic">(window reflex)</span>.</p></li>
<li><p class="">In 1880, Placido introduced a disc <span class="italic">(Placido's disc)</span> with alternate white and dark concentric circles with central aperture for viewing. These circles were reflected on the cornea. A qualitative assessment was made.</p></li>
</ul>
<p class="indent">The invention of videography has been incorporated into the Placido image system. The image thus captured on a CCD camera and analyzed by computer software on the basis of relative distances between the rings. “Shorter the distance, steeper is the cornea” and vice versa. Normal cornea is a prolate surface, i.e., steeper in the center and flatter in the periphery.</p>
<p class="indent">The computer adds chosen color to the image and produces a color-coded map of the whole cornea. By standardization the:</p>
<ul style="list-style-type: bullet">
<li><p class=""><span class="italic">Warm (hot) colors</span> such as red, yellow represent high corneal power <span class="italic">(steeper)</span>.</p></li>
<li><p class=""><span class="italic">Cool colors</span> like violet, blue represent low corneal power <span class="italic">(flatter)</span>.</p></li>
<li><p class=""><span class="italic">Yellow-green spectrum</span> represents the most normal corneas.</p></li>
</ul>
<p class="indent">A scale is given alongside the color-coded map which gives the numerical values in diopters to the specific colors.</p>
<div class="section" id="ch28lev2sec31"><h2 class="title">Uses</h2>
<ul style="list-style-type: bullet">
<li><p class="">The curvature of the whole cornea can be studied.</p></li>
<li><p class="">Early diagnosis of corneal ectatic disorders such as keratoconus, pellucid degeneration or secondary corneal ectasia, etc.</p></li>
<li><p class="">Study of changes in corneal astigmatism following surgical procedures like keratoplasty, cataract surgery, refractive surgeries, etc.<a name="page577"></a><span class="pageBreak"></span><span class="pageNumbers"><span class="bottomPage">577</span></span></p></li>
</ul>
</div>
</div><div class="section" id="ch28lev1sec13"><h1 class="title">CORNEAL TOMOGRAPHY</h1>
<p class="noindent"><bold>Corneal topography</bold> is an imaging technique for mapping the surface curvature and shape of the <bold>anterior</bold> corneal surface <bold>(<a href="#ch28fig12" class="ulink-inter">Figs. 28.12A and B</a>)</bold>.</p>
<p class="indent">On the other hand, <bold>corneal tomography</bold> computes a 3-D image of the cornea, and assesses the entire cornea, <bold>anterior</bold> and <bold>posterior</bold> surfaces. It characterizes the elevation of the front and back corneal surfaces and reconstructs the pachymetry mapping, which has significantly enhanced the sensitivity and specificity for detecting corneal ectasia.</p>
<p class="indent">The values are coded with colored maps. These range from warm colors (red, orange, yellow), to neutrals (green) to cool colors (blue, purple).</p>
<p class="indent">In Oculyzer images, <bold>we see four different types of maps (<a href="#ch28fig12" class="ulink-inter">Fig. 28.12C</a>):</bold></p>
<ol style="list-style-type: decimal">
<li><p class=""><bold>Axial map (top left):</bold> Useful for assessing irregularity of astigmatism and planning suture removal after PK.</p></li>
<li><p class=""><bold>Corneal thickness, or pachymetry map (bottom left):</bold> Displays distribution of corneal thicknesses across the entire measured area.</p>
<p class=""><div class="figure" id="ch28fig12" data-label="Figs. 28.12A to C"><div class="title"><span class="item-label">Figs. 28.12A to C</span> <bold>A.</bold> Normal corneal topography; <bold>B.</bold> Corneal topography in keratoconus; <bold>C.</bold> Corneal tomography (Oculyzer).</div><img alt="Figs. 28.12A to C" src="/MediumImage/577-1.jpg"><div class="additional-markup"></div></div></p></li>
<li><p class=""><a name="page578"></a><span class="pageBreak"></span><span class="pageNumbers"><span class="bottomPage">578</span></span><bold>Anterior elevation map (top right):</bold> Useful for assessing regularity of astigmatism, location of astigmatism and surgical planning for AK, toric planning.</p></li>
<li><p class=""><bold>Posterior elevation map (bottom right):</bold> Useful for identifying forme fruste keratoconus.</p></li>
</ol>
<p class="indent">For <bold>corneal tomography</bold>, scanning slit or Scheimpflug imaging and optical coherence tomography may be employed.</p>
<p class="indent">In several devices, <bold>corneal topography and tomography</bold>—both have been successfully combined with tear-film analysis, aberrometry, optical biometry and anterior/posterior segment optical coherence tomography.</p>
<div class="section" id="ch28lev2sec32"><h2 class="title">Uses of Corneal Tomography</h2>
<ul style="list-style-type: bullet">
<li><p class="">To screen for refractive surgery candidates—by identifying irregular astigmatism and helping estimate postoperative risk of ectasia</p></li>
<li><p class="">To detection of ectatic corneal disorders such as keratoconus, pellucid marginal degeneration and post-LASIK ectasia</p></li>
<li><p class="">Management of astigmatism in cataract surgery and after keratoplasty</p></li>
<li><p class="">To determine visual significance of corneal/conjunctival lesions, such as pterygium and Salzmann's nodular degeneration</p></li>
<li><p class="">For guidance of suture removal and placement of corneal relaxing incisions in keratoplasty.</p></li>
</ul>
</div>
</div><div class="section" id="ch28lev1sec14"><h1 class="title">SPECULAR MICROSCOPY</h1>
<p class="noindent">The ophthalmologist can visualize the corneal endothelium directly by performing specular reflection method of slit-lamp microscope. But this is not enough to get sufficient information about cell density and morphology of the corneal endothelium.</p>
<p class="indent">Specular microscope is a useful instrument to visualize the corneal endothelium (at 500 x) to the ophthalmologists, especially the corneal surgeons.</p>
<p class="indent">It yields information that guides the physician in decision-making of certain corneal disorders and anterior segment surgeries. It also captures the pictures that are useful for documentation and monitoring a patient over a period of time.</p>
<p class="indent">The corneal endothelium is a hexagonal monolayer that does not divide in human being.</p>
<p class="indent">The cell count of an infant is around 4,500–5,000 cells/sq. mm. With age, the cell count decreases at the rate of average 0.6% per year. The adults typically have 2,000–3,000 cell/sq. mm. of endothelium. The cell morphology is also changed with ages. In young adult, the percentage of hexagonal cells is more (&gt;60%).</p>
<p class="indent">The <span class="italic">critical endothelial cell</span> count is around 500 cell/sq. mm. If the cell count is less than 500 cells/sq. mm, there may be chance of corneal decompensation and corneal edema <bold>(<a href="#ch28fig13" class="ulink-inter">Figs. 28.13A and B</a>)</bold>.</p>
<div class="section" id="ch28lev2sec33"><h2 class="title">Specular Microscopy Analysis</h2>
<ul style="list-style-type: bullet">
<li><p class=""><span class="italic">Cell density (CD):</span> Number of endothelial cells/sq.mm.</p></li>
<li><p class=""><span class="italic">Hexagonality:</span> Percentage of hexagonal cells among total endothelial cells.</p></li>
<li><p class=""><span class="italic">Cell size and shape:</span> Percentage of cells that show polymegethism (different cell sizes) and pleomorphism (different cell shapes).</p></li>
<li><p class=""><span class="italic">Coefficient of variation of cell size:</span> An automatic statistical index of polymegethism.</p></li>
<li><p class=""><span class="italic">Corneal thickness (CT):</span> It gives the measurement of corneal thickness in µm in a noncontact way.</p></li>
</ul>
<p class="indent">The additional software algorithm can analyze in depth the morphological changes of the corneal endothelium and can compare the results with other values.</p>
<p class="indent">Both contact and noncontact specular microscope are available. But practically, noncontact specular is more safe and popular.</p>
<p class="noindent"><span class="italic">Two types of specular microscopes:</span></p>
<ol style="list-style-type: decimal">
<li><p class=""><span class="italic">Clinical specular:</span> To study the endothelium in a clinical set-up.<a name="page579"></a><span class="pageBreak"></span><span class="pageNumbers"><span class="bottomPage">579</span></span></p>
<p class=""><div class="figure" id="ch28fig13" data-label="Figs. 28.13A and B"><div class="title"><span class="item-label">Figs. 28.13A and B</span> <bold>A.</bold> Normal specular microscopic photograph; <bold>B.</bold> Corneal guttata with low endothelial cell count in early Fuchs’ dystrophy.</div><img alt="Figs. 28.13A and B" src="/MediumImage/579-1.jpg"><div class="additional-markup"></div></div></p></li>
<li><p class=""><span class="italic">Eye bank specular:</span> To study the sclerocorneal donor button for keratoplasty purpose.</p></li>
</ol>
</div>
<div class="section" id="ch28lev2sec34"><h2 class="title">Uses</h2>
<ul style="list-style-type: bullet">
<li><p class="">To study the corneal endothelial diseases.</p></li>
<li><p class="">To take decision about corneal surgery.</p></li>
<li><p class="">Before cataract operation when there is any suspicion during slit-lamp examination <span class="italic">(see</span> <a href="/9789356963825/chapter/ch15" class="ulink-exter">Chapter 15</a>).</p></li>
<li><p class="">To study the safety of certain surgical procedures.</p></li>
<li><p class="">To study the safety of certain drugs used intracamerally during surgery.</p></li>
<li><p class="">During follow-up of keratoplasty and refractive surgery patients.</p></li>
</ul>
</div>
</div><div class="section" id="ch28lev1sec15"><h1 class="title">SCANNING LASER POLARIMETRY (GDXVCC) (<a href="#ch28fig14" class="ulink-inter">FIGS. 28.14A AND B</a>)</h1>
<p class="noindent">Glaucoma detection with variable corneal compensation (GDxVCC) is a scanning laser polarimeter which helps to assess the thickness of the retinal nerve fiber layer (RNFL) without dilatation.</p>
<p class="indent">Patients with early glaucoma having normal optic nerves and visual fields may have RNFL defects and thus, GDx VCC helps in diagnosing glaucoma in <span class="italic">preperimetric stage</span>.</p>
<p class="noindent"><span class="italic">Principle:</span> When polarized light passes through the RNFL, the birefringent properties of the axons cause polarized light to undergo a phase shift. The amount of phase shift or retardation is measured and is proportional to the thickness of RNFL. This technique is known as <span class="italic">scanning laser polarimetry</span>.</p>
<p class="indent">Using a near infrared <span class="italic">diode laser</span> (780 nm) RNFL thickness is measured in a 15° × 15° grid centered on the optic nerve head.</p>
<p class="indent">The readings obtained are compared to a normative database.</p>
<p class="indent">The colored printout includes images and various parameters along with the probability of deviation of such values in compare to the normal database. RNFL thickness is represented using a color scale, with <span class="italic">dark blue being the thinnest</span> and the <span class="italic">red being thickest</span>.</p>
<div class="section" id="ch28lev2sec35"><h2 class="title">Uses</h2>
<ul style="list-style-type: bullet">
<li><p class="">It is a noninvasive quick technique for diagnosis and monitoring of early glaucoma.</p></li>
<li><p class="">It may also be used as a screening tool for the “<span class="italic">glaucoma-suspect</span>” patients.<a name="page580"></a><span class="pageBreak"></span><span class="pageNumbers"><span class="bottomPage">580</span></span></p></li>
</ul>
<div class="figure" id="ch28fig14" data-label="Figs. 28.14A and B"><div class="title"><span class="item-label">Figs. 28.14A and B</span> GDx VCC pictures. <bold>A.</bold> Normal appearance of RNFL with normal thickness; <bold>B.</bold> Thinning of RNFL—more in right eye with advanced glaucoma and inferior part in left eye with early glaucoma.</div><img alt="Figs. 28.14A and B" src="/MediumImage/580-1.jpg"><div class="additional-markup"></div></div>
</div>
</div><div class="section" id="ch28lev1sec16"><h1 class="title">OPTICAL COHERENCE TOMOGRAPHY (<a href="#ch28fig15" class="ulink-inter">FIGS. 28.15A TO D</a>)</h1>
<p class="noindent">It is a new diagnostic tool mainly for the posterior segment disorders. It rapidly provides a quantifiable two (or three) dimensional cross section (tomography) of the retina.</p>
<p class="indent">Ultrasonography B-scan mechanism has a similarity with optical coherence tomography (OCT). But instead of dynamic echoes of sound used in USG, OCT relies on differential reflections of light. Spatial resolution of OCT is approximately 5 µm, whereas that of USG B-scan is approximately 150 µm.</p>
<p class="indent">Optical coherence tomography is based on the principle of low coherence interferometry. It uses an infrared incident beam of approximately 830 nm in wavelengths. The beam is focused on retina by a +78D lens.</p>
<p class="indent">Optical coherence tomography unit employs a Michaelson interferometer to compare the magnitude of back scattered and reflected light from the retina and demonstrates it as a false color coded image in two/three dimensions by software manipulations.</p>
<p class="indent">Different types of OCT imaging have been developed: Time domain and Fourier domain techniques. The main advantages of Fourier domain OCT are higher signal acquisition rates and higher sensitivity than time domain OCT.</p>
<div class="section" id="ch28lev2sec36"><h2 class="title">Uses of Optical Coherence Tomography</h2>
<ul style="list-style-type: bullet">
<li><p class=""><span class="italic">Macular imaging:</span> In today's clinical ophthalmology, OCT is used mainly for imaging in macular diseases, like:
<ul style="list-style-type: square">
<li><p class="">Diabetic macular edema</p></li>
<li><p class="">Macular edema related to retinal venous occlusions</p></li>
<li><p class="">Cystoid macular edema</p></li>
<li><p class="">Epiretinal membrane (ERM), with or without vitreomacular traction <bold>(<a href="#ch28fig15" class="ulink-inter">Fig. 28.15D</a>)</bold></p></li>
<li><p class="">Macular hole or pseudohole <bold>(<a href="#ch28fig15" class="ulink-inter">Fig. 28.15B</a>)</bold></p></li>
<li><p class="">Choroidal neovascular membranes (CNVMs)</p></li>
<li><p class="">Central serous chorioretinopathy and pigment epithelial detachment <bold>(<a href="#ch28fig15" class="ulink-inter">Fig. 28.15C</a>)</bold>.<a name="page581"></a><span class="pageBreak"></span><span class="pageNumbers"><span class="bottomPage">581</span></span></p>
<p class=""><div class="figure" id="ch28fig15" data-label="Figs. 28.15A to D"><div class="title"><span class="item-label">Figs. 28.15A to D</span> <bold>A.</bold> Normal optical coherence tomography; <bold>B.</bold> Macular hole with detached operculum; <bold>C.</bold> Central serous retinopathy; <bold>D.</bold> Vitreomacular traction.</div><img alt="Figs. 28.15A to D" src="/MediumImage/581-1.jpg"><div class="additional-markup"></div></div></p></li>
</ul></p></li>
<li><p class="">Anterior segment evaluation by anterior segment OCT.</p></li>
<li><p class="">Quantification of peripapillary RNFL analysis.</p></li>
</ul>
</div>
<div class="section" id="ch28lev2sec37"><h2 class="title">Anterior Segment Optical Coherence Tomography</h2>
<p class="noindent">Optical coherence tomography is a noncontact optical device that provides cross-sectional images and quantitative analysis of the ocular tissues in the anterior and posterior segment.</p>
<p class="noindent">Anterior segment OCT systems are categorized by the wavelength of the light sources.</p>
<ul style="list-style-type: bullet">
<li><p class="">Dedicated systems using 1,310 nm, e.g., Zeiss Visante, Heidelberg SL-OCT, Tomey CASIA.</p></li>
<li><p class="">Systems converted from a retinal scanner using 830 nm, e.g., Optovue, Zeiss Cirrus, Heidelberg Spectralis.</p></li>
</ul>
<p class="indent">A shorter wavelength (830 nm, near infrared) provides a higher axial resolution, but its imaging depth is limited. A longer wavelength (1,310 nm) provides deeper penetration.</p>
<div class="section" id="ch28lev3sec18"><h3 class="title">Uses</h3>
<ul style="list-style-type: bullet">
<li><p class=""><span class="italic">Refractive surgery and ectatic disorders:</span> Used in visualization of flap thickness, flap interface, and flap displacement post- LASIK.</p></li>
<li><p class=""><span class="italic">Assessment of Descemet membrane:</span> ASOCT can help in prognosis, e.g., planar/nonplanar, local/extensive detachment, and rupture of DM. Also useful in knowing the status of DM post PK, DMEK, DSAEK, e.g., lenticule detachment, fluid in the interface and status after rebubbling.</p></li>
<li><p class=""><span class="italic">Deep anterior lamellar keratoplasty (DALK), Descemet stripping endothelial keratoplasty (DSEK), Descemet's membrane endothelial keratoplasty (DMEK):</span> Live intraoperative OCT (iOCT) is useful while performing DALK, DSEK and DMEK, e.g., dissection depth, insertion depth of cannula for big bubble technique, lenticule insertion in DMEK and its attachment and interface quality.</p></li>
<li><p class=""><span class="italic">Corneal deposits:</span> Useful in diagnosis of corneal dystrophies. Useful in the planning of PTK for superficial opacities, as in granular dystrophy.</p></li>
<li><p class=""><span class="italic">Keratitis:</span> Useful in knowing the depth of the infiltrate and can help in the planning of therapeutic PK vs. therapeutic DALK.</p></li>
<li><p class=""><span class="italic">Tumors and OSSN:</span> It has a supplementary role in some nonpigmented tumors.<a name="page582"></a><span class="pageBreak"></span><span class="pageNumbers"><span class="bottomPage">582</span></span></p></li>
<li><p class=""><span class="italic">Dry eye:</span> Useful in tear meniscus measurement viz. tear meniscus height (TMH), tear meniscus depth (TMD) and tear meniscus area (TMA).</p></li>
<li><p class=""><span class="italic">Cataract surgery:</span> Useful in femtosecond assisted cataract surgery where a live image of the cornea and lens is available for detailed planning of main port, side ports, relaxing incisions, and capsulorhexis.</p></li>
</ul>
</div>
</div>
<div class="section" id="ch28lev2sec38"><h2 class="title">Optical Coherence Tomography in Glaucoma</h2>
<ul style="list-style-type: bullet">
<li><p class=""><span class="italic">Angle assessment:</span> Anterior segment OCT can provide important parameters about the anterior chamber, like the anterior chamber angle (ACA), angle opening distance (AOD 500 and 750 μm) and trabecular iris space area (TISA).</p>
<p class="">These parameters help in—angle assessment especially in angle closure screening, structural cause of angle closure, evaluation of efficacy of a laser iridotomy procedure and analysis of iris configuration.</p></li>
<li><p class=""><span class="italic">Filtering bleb and tube:</span> ASOCT can reveal morphology of filtering blebs, the recently developed 3D ASOCT technique allows for a detailed evaluation of internal morphology of blebs. It can help determining which blebs are suitable for needling and for visualizing tube erosion in glaucoma drainage devices.</p></li>
<li><p class=""><span class="italic">Glaucoma diagnosis and progression:</span> ASOCT allows for in vivo cross-sectional imaging of the optic nerve head (ONH) and retina.</p></li>
</ul>
<p class="indent">Spectral domain optical coherence tomography (SDOCT) with 3D images helps in glaucoma diagnosis by studying the RNFL thickness, rim area, and total macular thickness.</p>
<p class="indent">Ganglion cell layer with inner plexiform layer (GCIPL) is the most sensitive parameter for the diagnosis of glaucoma.</p>
<p class="indent">SDOCT is useful in detecting RNFL changes in glaucoma progression. SDOCT glaucoma progression algorithms measure changes based on either eventbased or trendbased analysis.</p>
</div>
<div class="section" id="ch28lev2sec39"><h2 class="title">Retinal Nerve Fibers Layer (RNFL) OCT</h2>
<ul style="list-style-type: bullet">
<li><p class="">Optical coherence tomography technology can be used to quantitatively measure the thickness of the RNFL to assess glaucoma induced retinal nerve fiber damage.</p></li>
<li><p class="">The newer OCT machines allow highly precise measurements. And since anatomical changes precedes field loss, RNFL OCT is a pre-perimetric test which allows detection of glaucomatous damage even before the patient is aware of any field loss. This makes it a valuable glaucoma screening test.</p></li>
<li><p class="">RNFL is measured in microns in the peripapillary region with circular scan of 3.4 mm diameter centered around the optic nerve head.</p></li>
<li><p class="">These measurements are arranged in <bold>TSNIT</bold> order <bold>(T</bold>emporal – <bold>S</bold>uperior – <bold>N</bold>asal – <bold>I</bold>nferior – <bold>T</bold>emporal) and are compared with age-gender matched normative data.</p></li>
<li><p class="">The test result shows the RNFL thickness in a graphical pattern and are color coded as green (normal), yellow (suspicious) and red (abnormal) <bold>(<a href="#ch28fig16" class="ulink-inter">Figs. 28.16A and B</a>)</bold>.</p></li>
</ul>
<p class="indent">Subsequent tests can also pick up subtle thinning in each quadrant and is used to assess glaucoma progression.</p>
</div>
</div><div class="section" id="ch28lev1sec17"><h1 class="title">HEADACHE IN OPHTHALMOLOGY</h1>
<ul style="list-style-type: bullet">
<li><p class=""><span class="italic">“Headache”</span> is defined by the dictionary, as continuous or prolonged dull pain in the region of the head.</p></li>
<li><p class="">It is the <span class="italic">most frequent and most ill-understood clinical symptom</span>, which depends to a great deal on the emotional background and pain threshold of the subject.</p></li>
<li><p class="">Headache is usually mild, vague, brief lasting, and often innocuous, <span class="italic">but some-times</span>, it is severe, persistent, or frequent, and could be a symptom of more serious conditions in an apparently healthy individual.<a name="page583"></a><span class="pageBreak"></span><span class="pageNumbers"><span class="bottomPage">583</span></span></p></li>
</ul>
<div class="figure" id="ch28fig16" data-label="Figs. 28.16A and B"><div class="title"><span class="item-label">Figs. 28.16A and B</span> <bold>A.</bold> Normal image of RNFL OCT; <bold>B.</bold> Image of RNFL OCT in glaucoma.</div><img alt="Figs. 28.16A and B" src="/MediumImage/583-1.jpg"><div class="additional-markup"></div></div>
<ul style="list-style-type: bullet">
<li><p class="">So, a patient presenting with headache as a primary symptom to an ophthalmologist, often presents a diagnostic challenge.</p></li>
</ul>
<div class="section" id="ch28lev2sec40"><h2 class="title">Causes of Ocular Headache</h2>
<ul style="list-style-type: bullet">
<li><p class="">Associated with refractive errors and ocular muscle imbalance.</p></li>
<li><p class="">Secondary to organic diseases of the eye.</p></li>
<li><p class="">Due to systemic disorders, but have prominent ocular symptoms.</p></li>
</ul>
<p class="noindent"><span class="italic">Headache associated with refractive errors and ocular-muscle imbalance:</span></p>
<ul style="list-style-type: bullet">
<li><p class="">Majority of the patients with ocular headache belong to this category, and the <a name="page584"></a><span class="pageBreak"></span><span class="pageNumbers"><span class="bottomPage">584</span></span>pain is dull, boring and often associated with eye-strain.</p></li>
<li><p class="">Headaches are usually experienced towards the afternoon, and typically, experienced on undertaking tasks which entail binocular vision, e.g., reading, writing, knitting, etc.</p></li>
<li><p class="">Long-hour use of digital devices, such as—computer, laptop, tablets or even smart phone—is a cause of digital eye strain which may lead to headache.</p></li>
<li><p class=""><span class="italic">Conditions responsible</span>
<ul style="list-style-type: square">
<li><p class=""><span class="italic">Astigmatism and hypermetropia:</span> Low grades of error cause more headache, because the ciliary muscle tries to overcome the defect by spasm. But this element is lacking in higher errors, which present as visual deficit than headache.</p></li>
<li><p class=""><span class="italic">Presbyopia</span> (mainly on near work)</p></li>
<li><p class=""><span class="italic">Heterophoria (latent squint)</span></p></li>
<li><p class=""><span class="italic">Convergence insufficiency</span></p></li>
</ul></p></li>
<li><p class="">These headaches are relieved by proper glasses and orthoptic exercises.</p></li>
</ul>
<p class="noindent"><span class="italic">Headache secondary to organic eye-diseases:</span></p>
<ul style="list-style-type: bullet">
<li><p class="">These headaches are usually unilateral, acute, continuous and located in and around the eyeball, and often aggravated by light.</p></li>
<li><p class="">The pain is characteristically radiated along the sensory distribution of trigeminal nerve.</p></li>
<li><p class="">The patients often have sudden blurring of vision.</p></li>
<li><p class=""><span class="italic">The important causes:</span>
<ul style="list-style-type: square">
<li><p class="">Angle closure glaucoma</p></li>
<li><p class="">Acute iridocyclitis</p></li>
<li><p class="">Scleritis</p></li>
<li><p class="">Acute keratitis due to infection, contact lens overwear, or photokeratitis.</p></li>
</ul></p></li>
<li><p class="">Treatment is directed towards the cause.</p></li>
</ul>
<p class="noindent"><span class="italic">Ocular headache related to systemic diseases:</span> This category includes the more serious diseases:</p>
<ul style="list-style-type: bullet">
<li><p class="">Raised intracranial tension</p></li>
<li><p class="">Malignant hypertension</p></li>
<li><p class="">Migraine</p></li>
<li><p class="">Temporal arteritis</p></li>
<li><p class="">Psychogenic (e.g., anxiety neurosis).</p></li>
</ul>
</div>
<div class="section" id="ch28lev2sec41"><h2 class="title">Ophthalmic Evaluation of Headache</h2>
<ul style="list-style-type: bullet">
<li><p class=""><span class="italic">Refraction under cycloplegia</span></p></li>
<li><p class="">Ocular movements</p></li>
<li><p class=""><span class="italic">Orthoptic check-up</span></p></li>
<li><p class="">Slit lamp examination—to detect abrasion, ciliary congestion, KPs, etc.</p></li>
<li><p class="">Ophthalmoscopy to check <span class="italic">papilledema</span></p></li>
<li><p class="">Cranial nerve examinations</p></li>
<li><p class="">Intraocular pressure measurement</p></li>
<li><p class="">Gonioscopy to know the angle status</p></li>
<li><p class="">Palpation of the temporal artery for tenderness</p></li>
<li><p class="">Automated perimetry for visual field.</p></li>
</ul>
</div>
<div class="section" id="ch28lev2sec42"><h2 class="title">Ophthalmologist's Approach</h2>
<ul style="list-style-type: bullet">
<li><p class="">The ophthalmologists are responsible for the management of headache due to refractive errors and ocular muscle imbalance, and those secondary to organic eye diseases.</p></li>
<li><p class="">But, for the headaches related to systemic disease, his basic responsibility in early diagnosis (may be of an intracranial neoplasm by detecting the papilledema) and quick referral to other colleagues.</p></li>
<li><p class="">On the other hand, every case of headache must undergo a thorough ophthalmological check-up, and general practitioner can play an important role to select such cases for proper referral.</p></li>
</ul>
</div>
</div><div class="section" id="ch28lev1sec18"><h1 class="title">COMPUTER VISION SYNDROME (CVS)</h1>
<p class="noindent">Also called as Digital eye strain, is a complex of various ocular and peri-ocular symptoms caused by prolonged use of computer, tablets and smartphones. Between 50–90% of people who work at a computer screen for 6–9 hours have at least some symptoms. This is also common in children who stare at tablets, smartphone or gaming devices can have the <a name="page585"></a><span class="pageBreak"></span><span class="pageNumbers"><span class="bottomPage">585</span></span>same problems. CVS symptoms are more with small screen smartphones devices than large screen tablets/computers.</p>
<p class="noindent"><span class="italic">The common symptoms are:</span></p>
<ul style="list-style-type: bullet">
<li><p class="">Redness,</p></li>
<li><p class="">Dry eyes (evaporative type),</p></li>
<li><p class="">Blurred vision and double vision,</p></li>
<li><p class="">Eye strain,</p></li>
<li><p class="">Headache and brow-ache, and</p></li>
<li><p class="">Stiffness of neck and shoulders.</p></li>
</ul>
<p class="noindent"><span class="italic">The reasons for these symptoms are:</span> Decreased blink rate while staring at the screen, constant accommodation for long duration, blue light, glare from screen, poor lighting, improper viewing distance and sitting posture.</p>
<p class="noindent"><span class="italic">Treatment:</span> It consists primarily of ergonomic and lifestyle modifications.</p>
<ul style="list-style-type: bullet">
<li><p class="">Dry-eye component is treated with lubricants</p></li>
<li><p class="">Correct sitting position and viewing distance</p></li>
<li><p class="">Anti-glare eyeglasses; reduce screen brightness etc.</p></li>
<li><p class="">Frequent blinking and making conscious effort to blink (15–20 times/minutes)</p></li>
<li><p class=""><span class="italic">20-20-20 rule:</span> Every 20 minutes interval look at 20 feet distant object for 20 seconds. This relieves constant accommodation</p></li>
<li><p class="">Lubricants/artificial tears drops in between work (every two hourly during long session of computer works)</p></li>
<li><p class="">Cut down on excessive screen use in any form.</p></li>
</ul>
</div><div class="section" id="ch28lev1sec19"><h1 class="title">MIGRAINE (<a href="#ch28tbl2" class="ulink-inter">TABLE 28.2</a>)</h1>
<p class="noindent">It is a familial disorder characterized by:</p>
<ul style="list-style-type: bullet">
<li><p class="">Recurrent attacks of headache, widely varied in intensity, frequency and duration.</p></li>
</ul>
<div class="table" id="ch28tbl2"><div class="title"><span class="item-label">TABLE 28.2</span> Features of different types of migraine.</div><div class="table-scroll"><table data-label="TABLE 28.2" class="download">


<thead>
<tr>
<th class="left"><p class=""><span class="italic">Types</span></p></th>
<th class="left"><p class=""><span class="italic">Characteristic features</span></p></th>
</tr>
</thead>
<tbody>
<tr>
<td class="left"><p class=""><bold>Classical migraine</bold></p></td>
<td class="left"><p class="">
<ul style="list-style-type: bullet">
<li><p class="">Severe hemicranial throbbing pain</p></li>
<li><p class="">Preceded by an aura for 15 to 20 minutes</p></li>
<li><p class="">Visual symptoms are common, e.g., scintillating scotoma. In the dark field, zig-zag rays of various color are often seen, called ‘fortification spectra’ <span class="italic">(teichopsia)</span></p></li>
<li><p class="">Sensory symptoms include paresthesia and numbness</p></li>
</ul></p></td>
</tr>
<tr>
<td class="left"><p class=""><bold>Common migraine</bold></p></td>
<td class="left"><p class="">
<ul style="list-style-type: bullet">
<li><p class="">More common</p></li>
<li><p class="">Severe headache lasts for hours to 1–2 days</p></li>
<li><p class="">Associated with nausea, vomiting, and anorexia</p></li>
<li><p class="">No prodrome, no aura</p></li>
</ul></p></td>
</tr>
<tr>
<td class="left"><p class=""><bold>Basilar migraine</bold></p></td>
<td class="left"><p class="">
<ul style="list-style-type: bullet">
<li><p class="">Bilateral visual symptoms with headache</p></li>
<li><p class="">Associated features of vertebrobasilar insufficiency (e.g., tinnitus, ataxia, vertigo)</p></li>
<li><p class="">More common in adolescent girls</p></li>
</ul></p></td>
</tr>
<tr>
<td class="left"><p class=""><bold>Ophthalmoplegic migraine</bold></p></td>
<td class="left"><p class="">
<ul style="list-style-type: bullet">
<li><p class="">Common in children below 10 years of age</p></li>
<li><p class="">Ocular cranial nerve palsy (3rd most common)</p></li>
<li><p class="">Spontaneous recovery is common</p></li>
</ul></p></td>
</tr>
<tr>
<td class="left"><p class=""><bold>Complicated migraine</bold></p></td>
<td class="left"><p class="">
<ul style="list-style-type: bullet">
<li><p class="">Associated with neurological deficit lasting for more than 24 hours after the headache</p></li>
</ul></p></td>
</tr>
<tr>
<td class="left"><p class=""><bold>Hemiplegic migraine</bold></p></td>
<td class="left"><p class="">
<ul style="list-style-type: bullet">
<li><p class="">Associated with hemiplegia which outlasts headache</p></li>
</ul></p></td>
</tr>
<tr>
<td class="left"><p class=""><bold>Retinal migraine</bold></p></td>
<td class="left"><p class="">
<ul style="list-style-type: bullet">
<li><p class="">Headache associated with transient unilateral visual loss</p></li>
</ul></p></td>
</tr>
<tr>
<td class="left"><p class=""><bold>Migraine equivalent</bold></p></td>
<td class="left"><p class="">
<ul style="list-style-type: bullet">
<li><p class="">Auras occurring in isolation without headache</p></li>
<li><p class="">May be associated with abdominal pain</p></li>
<li><p class="">A variant of migraine</p></li>
</ul></p></td>
</tr>
<tr>
<td class="left"><p class=""><bold>Cluster headache</bold></p></td>
<td class="left"><p class="">
<ul style="list-style-type: bullet">
<li><p class="">Severe unilateral headache in clusters, several times daily for several days or weeks</p></li>
<li><p class="">It is worse at night, and aggravated by alcohol ingestion</p></li>
</ul></p></td>
</tr>
</tbody>
</table></div><div class="additional-markup"></div></div>
<ul style="list-style-type: bullet">
<li><p class=""><a name="page586"></a><span class="pageBreak"></span><span class="pageNumbers"><span class="bottomPage">586</span></span>Attacks are commonly unilateral, and usually associated with anorexia, nausea or vomiting.</p></li>
<li><p class="">In some cases, they are preceded by, or associated with neurological and mood disturbances.
<ul style="list-style-type: square">
<li><p class=""><span class="italic">Incidence:</span> About 5–10%.</p></li>
<li><p class=""><span class="italic">Age and sex:</span> It usually begins in childhood or early adult life, and is more common in women.</p></li>
<li><p class=""><span class="italic">Pathophysiology:</span> Migraine represents a disorder of cerebrovascular regulation. In a typical migraine, there is cerebral vasoconstriction decrease in O<sub>2</sub> supply brain cell hypoxia biochemical and vascular changes reactive extracranial vasodilation leading to typical headache.</p>
<p class=""><span class="italic">Vasoconstriction</span> initiates the prodromal symptoms including the neurological manifestations, and is due to:</p></li>
<li><p class="">Release of serotonin and thromboxane A<sub>2</sub> from platelets <span class="italic">(vascular theory)</span>.</p></li>
<li><p class="">Substance P, a neuro-transmitter <span class="italic">(neurogenic theory)</span>.</p></li>
</ul></p></li>
<li><p class=""><span class="italic">Trigger factors:</span> Migraine is often precipitated by some extrinsic or intrinsic factors, e.g., alcohol, cheese, chocolate, dairy products, change in weather, oral contraceptive pill, menstruation, change in sleep habit, stress, fatigue, depression, etc.</p></li>
</ul>
<div class="section" id="ch28lev2sec43"><h2 class="title">Treatment of Migraine</h2>
<ul style="list-style-type: bullet">
<li><p class=""><span class="italic">Treatment for an acute attack:</span> It may include analgesics, antiemetics, sedatives, ergot derivatives and sometimes systemic steroids. Ergots should be used cautiously. New drug, Sumatriptan, a 5-HT-receptor agonist is highly effective for the treatment of an acute attack, with fewer side effects.</p></li>
<li><p class=""><span class="italic">Prophylactic therapy:</span> Prevention of future attacks is only considered with the frequency of attacks is more than two per months.</p>
<p class="">The agents are beta-blockers (e.g., propranolol), cyproheptadine, anti-depressants, calcium-channel blockers (e.g., flunarizine), methysergide, etc.</p></li>
<li><p class=""><span class="italic">Reduction of migraine trigger-factors:</span> Try to avoid all the “trigger factors” which may precipitate a migraine attack.</p></li>
</ul>
</div>
</div><div class="section" id="ch28lev1sec20"><h1 class="title">SMOKING AND EYE DISEASES</h1>
<p class="noindent">It is well known that smoking is a risk factor for heart disease and lung cancer; however, smoking can also lead to different eye diseases. Avoiding smoking, or taking steps to quit lowers the risk of vision impairment and vision loss.</p>
<p class="noindent"><span class="italic">Smokers are at higher risk for:</span></p>
<ul style="list-style-type: bullet">
<li><p class=""><span class="italic">Age-related macular degeneration (AMD):</span> Smokers are 3–4 times more likely to develop AMD than non-smokers.</p></li>
<li><p class=""><span class="italic">Cataract:</span> Heavy smokers (15 cigarettes/day or more) have 3 times the risk of cataract as non-smokers.</p></li>
<li><p class=""><span class="italic">Dry eye syndrome—</span>is twice more common among smokers than non-smokers. Smokers who wear contact lenses have four times the increased risk of infection.</p></li>
<li><p class=""><span class="italic">Grave's disease (thyroid ophthalmopathy)—</span>is an autoimmune disease of thyroid gland and smoking is a major significant risk factor.</p></li>
<li><p class=""><span class="italic">Diabetic retinopathy:</span> Complications of diabetes made worse by smoking which include diabetic retinopathy and maculopathy.</p></li>
<li><p class=""><span class="italic">Glaucoma:</span> Older smokers have a higher risk of developing increased eye pressure (intraocular pressure) as compared to non-smokers.</p></li>
<li><p class=""><span class="italic">Uveitis:</span> Uveitis is more common in smokers than non-smokers.</p></li>
<li><p class=""><span class="italic">Transient ischemic attack (TIA):</span> The most common cause of temporary vision loss is known as a transient ischemic attack. It is more commonly known as a TIA, or a “mini-stroke”.</p></li>
<li><p class=""><span class="italic">Pregnancy and smoking:</span> Smoking during pregnancy is associated with premature births (thus, more retinopathy of prematurity—ROP), and higher rates of strabismus, refractive errors, retinal and optic nerve problems.<a name="page587"></a><span class="pageBreak"></span><span class="pageNumbers"><span class="bottomPage">587</span></span></p></li>
</ul>
</div><div class="section" id="ch28lev1sec21"><h1 class="title">OCULAR CHANGES IN PREGNANCY</h1>
<p class="noindent">The possible pregnancy-associated eye changes are broad. Many of these changes resolve during the postpartum period. Management thus involves watching simple findings, referring the patient who may require medical or surgical treatment.</p>
<p class="noindent"><span class="italic">Ocular changes pregnancy may be of 3 categories:</span></p>
<ol style="list-style-type: decimal">
<li><p class="">Physiological changes,</p></li>
<li><p class="">Pregnancy-specific eye diseases, and</p></li>
<li><p class="">Changes in pre-existing eye diseases.</p></li>
</ol>
<p class="noindent"><span class="italic">Physiological changes</span></p>
<ul style="list-style-type: bullet">
<li><p class=""><span class="italic">Corneal change:</span> Changes in both thickness and curvature—making change in refractive status—causing contact lens intolerance; and <span class="italic">a contraindication for refractive surgery</span>.</p></li>
<li><p class="">Decrease in intraocular pressure (IOP)</p></li>
<li><p class="">Temporary ptosis—which may be bilateral.</p></li>
</ul>
<p class="noindent"><span class="italic">Pregnancy-specific eye diseases</span></p>
<ul style="list-style-type: bullet">
<li><p class="">Hypertensive retinopathy secondary to pregnancy induced hypertension or pre-eclampsia. Exudative retinal detachment (usually bilateral) occurs in &lt;1% of patients with preeclampsia and in 10% with eclampsia. Cortical blindness may also occur in pre-eclamptic and eclamptic women.</p></li>
<li><p class="">Retinal vascular occlusive disorders—due to hypercoagulable state of pregnancy or amniotic fluid embolism to retinal vessels.</p></li>
<li><p class="">Central serous retinopathy (CSR)—in women, it has a strong association with late pregnancy.</p></li>
<li><p class="">Pituitary apoplexy—field changes due to optic nerve compression.</p></li>
</ul>
<p class="noindent"><span class="italic">Changes in pre-existing eye diseases</span></p>
<ul style="list-style-type: bullet">
<li><p class=""><span class="italic">Diabetic retinopathy (DR) progression:</span> Pregnancy is an independent risk factor for worsening of DR. No risk of retinopathy with gestational diabetes. Women with diabetes who plan to become pregnant should have a pre-pregnancy dilated fundus examination. During pregnancy, fundus examination to be performed in each trimester.</p></li>
<li><p class=""><span class="italic">Keratoconus:</span> Pregnancy is a risk factor for progression of keratoconus. In some eyes, there may be development of acute hydrops. Close follow-up is required for patient with keratoconus during pregnancy and corneal collagen crosslinking with riboflavin (C3R) is contraindicated.</p></li>
<li><p class=""><span class="italic">For chronic non-infectious uveitis:</span> Pregnancy may have a beneficial effect, possibly due to hormonal and immunomodulatory mechanisms.</p></li>
<li><p class="">Latent ocular toxoplasmosis may reactivate during pregnancy, with a negligible risk to the fetus of acquiring congenital toxoplasmosis. Spiramycin is preferred over pyrimethamine as a safer alternative in pregnant women.</p></li>
</ul>
</div><div class="section" id="ch28lev1sec22"><h1 class="title">OCULAR MANIFESTATIONS OF COVID-19</h1>
<p class="noindent"><span class="italic">Coronavirus</span> disease 2019 (COVID-19) was announced as a global pandemic on 11th March 2020 by the World Health Organization, designated as SARS-CoV-2 by the International Virus Classification Board. The pandemic has caused great morbidity and mortality in the world, responsible for the death of 6.8 million people worldwide, by March, 2023. <span class="italic">Dr Li Wenliang, an ophthalmologist in Wuhan, Hubei, China, was the first doctor to notify and warn for its severity and rapid spread. In a tragic turn of events, he subsequently contracted SARS-CoV-2 and died.</span></p>
<p class="indent">One of the important organs involved during COVID-19 (and also a transmission route of the disease), is the EYE. The pathophysiology of the eye involvement during COVID-19 is attributed to—the direct effect of the virus on the eyes, ocular tissue damage caused by inflammation, underlying diseases, and the adverse effect of the medications or vaccination. Furthermore, this virus evolves over time and has had several mutations so far, resulting in different subtypes (alpha, beta, gamma, delta and omicron), which can have diverse presentations.<a name="page588"></a><span class="pageBreak"></span><span class="pageNumbers"><span class="bottomPage">588</span></span></p>
<p class="noindent"><span class="italic">The ocular manifestations may be grouped as:</span></p>
<ol style="list-style-type: decimal">
<li><p class=""><bold>Ocular surface, anterior segment and eyelid manifestations:</bold></p>
<ul style="list-style-type: square">
<li><p class=""><span class="italic">Ocular surface and cornea:</span> Conjunctivitis, unilateral or bilateral, is the most common ocular manifestation of COVID-19.</p>
<p class="">In addition to conjunctivitis, patients may develop other ocular surface disorders, such as keratitis, pseudomembranous keratoconjunctivitis, conjunctival follicular reaction, episcleritis, hemorrhagic conjunctivitis;</p></li>
<li><p class=""><span class="italic">Eyelid:</span> Eyelid manifestation can present as blepharitis, eyelid edema, eyelid dermatitis, meibomian orifice abnormalities, and lid margin hyperemia.</p></li>
</ul></li>
<li><p class=""><bold>Posterior segment manifestations:</bold> Posterior segment involvement reflects the effect of the virus on vascular, inflammatory, and neuronal properties of the eye. They are: cotton wool spots, retinal hemorrhage, central serous retinopathy, optic neuritis, optic atrophy, pan uveitis, multifocal retinitis, necrotizing retinitis, central retinal artery/vein occlusion and acute retinal necrosis.</p>
<ul style="list-style-type: square">
<li><p class=""><span class="italic">Central retinal vein occlusion (CRVO):</span> Microvascular changes are the most common vitreoretinal disorder caused by COVID-19 infection.</p></li>
<li><p class=""><span class="italic">Bilateral vitritis</span> with bilateral redness, and associated with yellowish macular lesions.</p></li>
<li><p class=""><span class="italic">Choroid and uvea:</span> Chorioretinitis is also reported to be caused by SARS-CoV-2.</p></li>
</ul></li>
<li><p class=""><bold>Neuro-ophthalmic manifestations:</bold></p>
<ul style="list-style-type: square">
<li><p class=""><span class="italic">Optic neuritis:</span> Bilateral optic neuritis</p></li>
<li><p class=""><span class="italic">Miller fisher syndrome and cranial nerve palsy:</span> Several cases of cranial nerve palsy (most commonly the 6th nerve, followed by the oculomotor nerve).</p></li>
<li><p class=""><span class="italic">Visual loss associated with CVA:</span> Stroke—an important and life-threatening complication of COVID-19, during which infarction of the occipital lobes can result in acute vision loss.</p></li>
</ul></li>
<li><p class=""><bold>Orbital manifestations:</bold></p>
<ul style="list-style-type: square">
<li><p class=""><span class="italic">Rhino-orbital cerebral mucormycosis (ROCM)</span>—is the most common orbital involvement. It is more common in patients with diabetes mellitus and who are suffering from critical or severe COVID-19.</p></li>
<li><p class="">Orbital cellulitis and sinusitis.</p></li>
</ul></li>
<li><p class=""><bold>Quarantine dry eye:</bold> Patients under quarantine are at risk for ocular surface changes and developing dry eye disease (DED), called ‘quarantine dry eye’. Online education in schools, colleges, and universities, work from home for industries and offices in most countries—leading to long-term use of digital devices and VDTs may disrupt the surface of the eye, resulting in DED and MGDs.</p></li>
<li><p class=""><bold>Post-vaccination ocular complications:</bold> Different types of ocular complications have been reported after COVID-19 vaccination—including herpetic keratitis, facial nerve palsy, new-onset thyroid ophthalmopathy, episcleritis, anterior scleritis, anterior uveitis, multifocal choroiditis, acute macular neuro-retinopathy, and central serious retinopathy. There are also several reports of post-vaccination corneal graft rejections.</p></li>
<li><p class=""><bold>Long-term manifestations:</bold> In COVID-19 the inflammatory response can cause blood clots to form. These clots may travel to reach the blood vessels of the eye. So, in long COVID in most cases—it affects the retina and brain.</p>
<ul style="list-style-type: square">
<li><p class="">Cotton wool spots</p></li>
<li><p class="">Retinal artery occlusion</p></li>
<li><p class="">Retinal vein occlusion</p></li>
<li><p class="">Vitreous hemorrhage</p></li>
<li><p class="">Increased incidence of diabetic retinopathy</p></li>
<li><p class="">Lastly, neuro-ophthalmological manifestations.</p></li>
</ul></li>
</ol>
</div></div></div>